Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:hepatocellular carcinoma
go back to main search page
Accession:DOID:684 term browser browse the term
Definition:A liver carcinoma that has_material_basis_in undifferentiated hepatocytes and located_in the liver. (DO)
Synonyms:exact_synonym: Childhood Hepatocellular Carcinoma;   HCC;   Hepatocellular Cancer;   Hepatocellular Carcinoma, Childhood Type, Somatic;   LCC;   adult liver cancer;   adult liver cancers;   hepatocellular cancers;   hepatocellular carcinomas;   hepatoma;   hepatomas;   liver cell carcinoma;   liver cell carcinomas
 narrow_synonym: HEPATOBLASTOMA;   HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION;   hepatitis B virus induced hepatocellular carcinoma;   hepatitis C virus induced hepatocellular carcinoma;   hepatitis virus-related hepatocellular carcinoma
 primary_id: MESH:D006528
 alt_id: OMIM:114550
 xref: EFO:0000182;   EFO:0000189;   EFO:0008503;   EFO:0008504;   EFO:0008505;   ICD-O:M8170/3;   NCI:C129298;   NCI:C24029;   NCI:C3099;   NCI:C38756;   NCI:C60416;   ORDO:88673
For additional species annotation, visit the Alliance of Genome Resources.



show annotations for term's descendants           Sort by:
hepatocellular carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin IEP
ISO
mRNA,protein:increased expression:liver:
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:15509519 PMID:15509519 RGD:1358261 NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
JBrowse link
G Aadat aminoadipate aminotransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:29,509,392...29,544,332
Ensembl chr16:29,509,394...29,544,332
JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 severity IEP
ISO
mRNA:decreased expression:liver (human) RGD PMID:16941710 PMID:30580964 RGD:1598532, RGD:24922199 NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A susceptibility IEP
ISO
CTD Direct Evidence: marker/mechanism
DNA:polymorphism: : c.1465C > T(human)
DNA:polymorphism: :c.3751G>A(human)
CTD
RGD
PMID:17510421 PMID:25625052 PMID:23488625 PMID:24175826 RGD:11041138, RGD:14700904, RGD:14700905 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 ISO
ISS
CTD Direct Evidence: marker/mechanism
OMIM:114550
CTD
MouseDO
PMID:22022477 NCBI chr 4:25,150,998...25,209,489
Ensembl chr 4:25,151,953...25,209,202
JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 IEP mRNA:increased expression:liver RGD PMID:25842354 RGD:11535155 NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
JBrowse link
G Abce1 ATP binding cassette subfamily E member 1 ISO mRNA:increased expression:liver (human) RGD PMID:21932399 RGD:11041873 NCBI chr19:28,205,566...28,230,489
Ensembl chr19:28,205,555...28,230,489
JBrowse link
G Abl1 ABL proto-oncogene 1, non-receptor tyrosine kinase ISO RGD PMID:32171747 RGD:126907997 NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
JBrowse link
G Acaca acetyl-CoA carboxylase alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
JBrowse link
G Ace angiotensin I converting enzyme susceptibility ISO CTD Direct Evidence: therapeutic
DNA:insertion/deletion:intron 16:
CTD
RGD
PMID:16328049 PMID:25208933 RGD:11343535 NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
JBrowse link
G Acer3 alkaline ceramidase 3 disease_progression ISO RGD PMID:30097213 RGD:35673325 NCBI chr 1:152,504,180...152,606,596
Ensembl chr 1:152,504,186...152,606,591
JBrowse link
G Acly ATP citrate lyase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
JBrowse link
G Aco2 aconitase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 7:113,385,677...113,428,794
Ensembl chr 7:113,385,646...113,428,261
JBrowse link
G Acox1 acyl-CoA oxidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12771043 PMID:15565109 NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232
JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr  X:105,942,794...106,006,573
Ensembl chr  X:105,942,799...106,006,427
JBrowse link
G Actb actin, beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 PMID:21472284 NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19514085 NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
JBrowse link
G Adamts13 ADAM metallopeptidase with thrombospondin type 1 motif, 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:10,299,264...10,338,464
Ensembl chr 3:10,300,028...10,346,687
JBrowse link
G Add1 adducin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182
JBrowse link
G Adgrg7 adhesion G protein-coupled receptor G7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:43,808,101...43,877,539
Ensembl chr11:43,813,801...43,876,316
JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing susceptibility ISO DNA:SNP:intron:+276T>G (rs1501299) (human) RGD PMID:23740135 RGD:14401720 NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
JBrowse link
G Adra1a adrenoceptor alpha 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr15:40,830,125...40,935,902
Ensembl chr15:40,832,534...40,927,500
JBrowse link
G Adra2b adrenoceptor alpha 2B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
JBrowse link
G Afp alpha-fetoprotein severity
disease_progression
treatment
ISO
IEP
protein:increased expression:serum (human)
associated with hepatitis B
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:9029167 PMID:15276417 PMID:24012840 PMID:28284560 PMID:32961231 More... RGD:14401581, RGD:126790579, RGD:126790583, RGD:125097525, RGD:152177911 NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
JBrowse link
G Aicda activation-induced cytidine deaminase ISO RGD PMID:18997814 RGD:127285629 NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
JBrowse link
G Ak3 adenylate kinase 3 ISO protein:decreased expression:liver RGD PMID:17203974 RGD:13842477 NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625
JBrowse link
G Akr1a1 aldo-keto reductase family 1 member A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32805337 NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 ISO
IEP
protein:increased expression:liver (human)
protein:increased expression:liver (rat)
RGD PMID:19422879 PMID:21683810 RGD:8548685, RGD:5509919 NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
JBrowse link
G Akt1 AKT serine/threonine kinase 1 treatment ISO
IEP
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hepatocellular cancer
CTD
ClinVar
RGD
PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 More... RGD:151893509, RGD:152177911 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
JBrowse link
G Akt2 AKT serine/threonine kinase 2 IEP
ISO
protein:increased phosphorylation:liver cancer cell (rat)
protein:increased phosphorylation:liver (mouse)
RGD PMID:19309364 PMID:28100771 RGD:2313299, RGD:127285675 NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
JBrowse link
G Alb albumin susceptibility ISO associated with hepatitis C;protein:decreased expression:serum
protein:decreased expression:serum (human)
ClinVar Annotator: match by term: Hepatocellular carcinoma
ClinVar
RGD
PMID:23892757 PMID:29040987 PMID:22392353 RGD:11035269, RGD:14694841, RGD:125097525 NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member susceptibility
severity
no_association
ISO associated with alcoholic liver cirrhosis;DNA:missense mutation:cds:p.E487K (human)
DNA:missense mutation:cds, exon 12:p.E487K (human)
associated with hepatitis C:DNA:SNP:exon 12 (human)
protein:decreased expression: liver (human)
mRNA, protein:decreased expression:liver (human)
DNA:missense mutation:cds: (rs671) (human)
associated with hepatitis B;DNA;missense mutation, haplotype:cds: (rs671) (human)
DNA:missense mutation:exon 12: (human)
associated with alcohol use disorder;DNA:missense mutation:cds: (human)
RGD PMID:25778454 PMID:1916152 PMID:12940444 PMID:26150517 PMID:28027570 More... RGD:11054822, RGD:14696699, RGD:14696778, RGD:14696779, RGD:15036809, RGD:14700899, RGD:15042857, RGD:15042859, RGD:15042862 NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
JBrowse link
G Aldh7a1 aldehyde dehydrogenase 7 family, member A1 severity ISO mRNA:altered expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
JBrowse link
G Aldoc aldolase, fructose-bisphosphate C IEP mRNA:increased expression:liver RGD PMID:3830170 RGD:2301136 NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
JBrowse link
G Alx4 ALX homeobox 4 ameliorates ISO
IEP
mRNA, protein:decreased expression:liver RGD PMID:28081728 PMID:31132711 PMID:31132711 RGD:153323329, RGD:153323330, RGD:153323330 NCBI chr 3:79,611,682...79,648,260
Ensembl chr 3:79,611,719...79,648,260
JBrowse link
G Angptl6 angiopoietin-like 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:19,413,619...19,419,925
JBrowse link
G Ank3 ankyrin 3 ISO protein:decreased expression:liver RGD PMID:26652480 RGD:153344559 NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
JBrowse link
G Anln anillin, actin binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538
JBrowse link
G Antxr1 ANTXR cell adhesion molecule 1 treatment ISO RGD PMID:20650339 RGD:9684932 NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232
JBrowse link
G Anxa10 annexin A10 disease_progression ISO mRNA:decreased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648
JBrowse link
G Anxa2 annexin A2 ISO mRNA, protein:increased expression:liver (human) RGD PMID:33675609 RGD:152999436 NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
JBrowse link
G Anxa4 annexin A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
JBrowse link
G Anxa6 annexin A6 disease_progression ISO associated with tumor vascularization; protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433
JBrowse link
G Apc APC regulator of WNT signaling pathway ISO
ISS
DNA:hypermethylation
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD Direct Evidence: marker/mechanism
OMIM:114550
OMIM
ClinVar
CTD
MouseDO
RGD
PMID:1316610 PMID:8381579 PMID:9824584 PMID:11466687 PMID:15311282 More... RGD:14402050 NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
JBrowse link
G Apcs amyloid P component, serum ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298
JBrowse link
G Apex1 apurinic/apyrimidinic endodeoxyribonuclease 1 treatment ISO
IEP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:25109342 PMID:33841550 RGD:152998960 NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
JBrowse link
G Apln apelin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:127,180,801...127,213,567
Ensembl chr  X:127,203,823...127,213,391
JBrowse link
G Apoa1 apolipoprotein A1 disease_progression ISO CTD Direct Evidence: marker/mechanism
protein:decreased expression:plasma (human)
associated with hepatitis B;
CTD
RGD
PMID:21472284 PMID:23935864 PMID:31211449 RGD:25671438, RGD:153350082 NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035
JBrowse link
G Apoa2 apolipoprotein A2 ISO associated with hepatitis B; mRNA:increased expression:liver RGD PMID:31211449 RGD:153350082 NCBI chr13:83,644,460...83,646,358
Ensembl chr13:83,644,470...83,646,355
JBrowse link
G Apoa4 apolipoprotein A4 disease_progression ISO associated with hepatitis B; RGD PMID:31211449 RGD:153350082 NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469
JBrowse link
G Apob apolipoprotein B ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
JBrowse link
G Apoc1 apolipoprotein C1 disease_progression ISO associated with hepatitis B; RGD PMID:31211449 RGD:153350082 NCBI chr 1:79,347,057...79,350,340
Ensembl chr 1:79,346,136...79,350,375
JBrowse link
G Apoc2 apolipoprotein C2 ISO associated with hepatitis B; mRNA:increased expression:liver RGD PMID:31211449 RGD:153350082 NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476
JBrowse link
G Apoc3 apolipoprotein C3 susceptibility
disease_progression
ISO associated with Chronic Hepatitis B;DNA:SNP: :rs2854116(human)
associated with hepatitis B;
RGD PMID:27547913 PMID:31211449 RGD:153344620, RGD:153350082 NCBI chr 8:46,531,478...46,533,658
Ensembl chr 8:46,531,478...46,533,583
JBrowse link
G Apoc4 apolipoprotein C4 disease_progression ISO associated with hepatitis B; RGD PMID:31211449 RGD:153350082 NCBI chr 1:79,335,745...79,339,942
Ensembl chr 1:79,335,745...79,339,981
JBrowse link
G Apoe apolipoprotein E ISO protein:increased expression:liver, serum (mouse) RGD PMID:21644509 RGD:6903288 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
JBrowse link
G Apof apolipoprotein F ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
JBrowse link
G Aprt adenine phosphoribosyl transferase IEP protein:increased activity:hepatoma (rat) RGD PMID:6327016 RGD:5135035 NCBI chr19:50,626,201...50,628,491
Ensembl chr19:50,626,202...50,628,431
JBrowse link
G Aqp7 aquaporin 7 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:24033266 NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:56,172,519...56,186,642
JBrowse link
G Ar androgen receptor ISO CTD Direct Evidence: therapeutic CTD PMID:18639551 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925
JBrowse link
G Arg1 arginase 1 disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:17210712 PMID:30901224 RGD:4140476, RGD:152995286 NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
JBrowse link
G Arhgap11a Rho GTPase activating protein 11A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:100,590,865...100,607,146
Ensembl chr 3:100,590,865...100,607,559
JBrowse link
G Arhgef39 Rho guanine nucleotide exchange factor 39 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:57,752,509...57,756,079
Ensembl chr 5:57,752,509...57,756,109
JBrowse link
G Arid1a AT-rich interaction domain 1A treatment
exacerbates
ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:liver (human)
mRNA, protein:decreased expression:liver (human)
associated with non-alcoholic steatohepatitis
human gene in mouse model
ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD
ClinVar
RGD
PMID:22561517 PMID:22634756 PMID:22922871 PMID:26589513 PMID:25975202 More... RGD:125097485, RGD:125097495, RGD:125097519, RGD:11344640, RGD:126790634, RGD:126790634 NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
JBrowse link
G Arid1b AT-rich interaction domain 1B ISO CTD Direct Evidence: marker/mechanism CTD PMID:22634756 NCBI chr 1:45,567,991...45,923,644
Ensembl chr 1:45,563,623...45,923,493
JBrowse link
G Arid2 AT-rich interaction domain 2 disease_progression
exacerbates
ISO CTD Direct Evidence: marker/mechanism
associated with hepatitis B;protein:decreased expression:liver
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD
ClinVar
RGD
PMID:21822264 PMID:22634756 PMID:32071245 PMID:27351279 PMID:28498550 More... RGD:150340708, RGD:150340711, RGD:150340712, RGD:150429631 NCBI chr 7:127,447,192...127,565,987
Ensembl chr 7:127,447,278...127,563,512
JBrowse link
G Arid3a AT-rich interaction domain 3A ISO CTD Direct Evidence: marker/mechanism CTD PMID:35179300 NCBI chr 7:9,755,291...9,781,260
Ensembl chr 7:9,755,294...9,780,599
JBrowse link
G Arrb2 arrestin, beta 2 treatment IEP RGD PMID:33841550 RGD:152998960 NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
JBrowse link
G Asf1b anti-silencing function 1B histone chaperone ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549
JBrowse link
G Asl argininosuccinate lyase disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
JBrowse link
G Asns asparagine synthetase (glutamine-hydrolyzing) IEP protein:increased activity:serum (rat) RGD PMID:10081 RGD:2316006 NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
JBrowse link
G Aspg asparaginase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:131,176,727...131,196,268
Ensembl chr 6:131,176,874...131,196,268
JBrowse link
G Aspm assembly factor for spindle microtubules disease_progression ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:28284560 PMID:18676753 RGD:13439743 NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
JBrowse link
G Ass1 argininosuccinate synthase 1 disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:12359751 PMID:30901224 RGD:4140479, RGD:152995286 NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
JBrowse link
G Atg101 autophagy related 101 disease_progression ISO RGD PMID:35592424 RGD:153350091 NCBI chr 7:132,398,477...132,407,643
Ensembl chr 7:132,398,483...132,407,633
JBrowse link
G Atg7 autophagy related 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29191453 NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593
JBrowse link
G Atm ATM serine/threonine kinase exacerbates ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)
CTD
RGD
PMID:12866955 PMID:19919837 RGD:126781750 NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
JBrowse link
G Atp5pb ATP synthase peripheral stalk-membrane subunit b ISO associated with hepatitis C RGD PMID:18932288 RGD:14696822 NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
JBrowse link
G Atp5pd ATP synthase peripheral stalk subunit d ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
JBrowse link
G Atp7b ATPase copper transporting beta onset IAGP RGD PMID:8291609 RGD:15036817 NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
JBrowse link
G Atp7bhts ATPase copper transporting beta; hepatitis onset IAGP RGD PMID:8291609 RGD:15036817
G Atxn1 ataxin 1 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:25741868 NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360
JBrowse link
G Aurka aurora kinase A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
JBrowse link
G Aurkb aurora kinase B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
JBrowse link
G Axin1 axin 1 disease_progression ISO CTD Direct Evidence: marker/mechanism
associated with Hepatitis B, Chronic,DNA:SNP, haplotype:exon:(rs1805105) T>C (human)
protein:decreased expression:liver (human)
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
OMIM
CTD
ClinVar
RGD
PMID:10700176 PMID:25741868 PMID:25822088 PMID:28492532 PMID:10700176 More... RGD:1300371, RGD:14402039, RGD:150530481, RGD:150530482 NCBI chr10:15,163,477...15,215,615
Ensembl chr10:15,163,684...15,215,615
JBrowse link
G Axin2 axin 2 ISO protein:increased expression:liver: RGD PMID:11809809 RGD:151356508 NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231
JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding disease_progression ISO
IEP
mRNA:decreased expression:liver RGD PMID:22625427 PMID:27993894 PMID:26902423 RGD:153350130, RGD:153350132, RGD:153350133 NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
JBrowse link
G Azin1 antizyme inhibitor 1 disease_progression ISO RNA:increased editing:liver RGD PMID:23291631 RGD:14700705 NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
JBrowse link
G Banf1 BAF nuclear assembly factor 1 treatment IEP
ISO
mRNA, protein:increased expression:liver (rat)
mRNA, protein:increased expression:liver (human)
RGD PMID:29059470 PMID:29059470 PMID:29059470 RGD:155791679, RGD:155791679, RGD:155791679 NCBI chr 1:202,672,170...202,674,215
Ensembl chr 1:202,671,305...202,674,188
JBrowse link
G Bax BCL2 associated X, apoptosis regulator treatment IEP RGD PMID:33841550 RGD:152998960 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
JBrowse link
G Bcl2 BCL2, apoptosis regulator treatment ISO
IEP
mRNA:increased expression:liver (mouse) RGD PMID:28100771 PMID:33841550 RGD:127285675, RGD:152998960 NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743
JBrowse link
G Bcl2l1 Bcl2-like 1 treatment ISO
IEP
CTD Direct Evidence: marker/mechanism|therapeutic
mRNA:increased expression:liver (mouse)
CTD
RGD
PMID:10629087 PMID:11509945 PMID:28100771 PMID:33841550 RGD:127285675, RGD:152998960 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
JBrowse link
G Bco2 beta-carotene oxygenase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:50,882,174...50,907,676
Ensembl chr 8:50,882,181...50,915,467
JBrowse link
G Bcorl1 BCL6 co-repressor-like 1 disease_progression ISO RGD PMID:29679906 PMID:26879601 RGD:150340705, RGD:11556159 NCBI chr  X:127,516,504...127,584,529
Ensembl chr  X:127,537,538...127,584,087
JBrowse link
G Bhmt betaine-homocysteine S-methyltransferase disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
JBrowse link
G Bhmt2 betaine-homocysteine S-methyltransferase 2 severity ISO mRNA:altered expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
JBrowse link
G Bid BH3 interacting domain death agonist ISO CTD Direct Evidence: marker/mechanism CTD PMID:15289866 NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 ameliorates
exacerbates
treatment
ISO human cell line in a mouse model
associated with hepatitis B;mRNA, protein:increased expression:liver (human)
RGD PMID:30368883 PMID:22682366 PMID:22820591 PMID:33310033 PMID:30210622 RGD:152998937, RGD:152998984, RGD:152998986, RGD:152998988, RGD:152999010 NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 disease_progression ISO CTD Direct Evidence: marker/mechanism|therapeutic
mRNA:increased expression:liver (human)
CTD
RGD
PMID:16086872 PMID:20514400 PMID:31964418 RGD:153344516 NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
JBrowse link
G Birc7 baculoviral IAP repeat-containing 7 exacerbates ISO mRNA:increased expression:liver (human) RGD PMID:31964418 RGD:153344516 NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
JBrowse link
G Blzf1 basic leucine zipper nuclear factor 1 disease_progression ISO RGD PMID:26342799 RGD:14398326 NCBI chr13:76,641,757...76,656,977
Ensembl chr13:76,641,515...76,656,999
JBrowse link
G Bmi1 BMI1 proto-oncogene, polycomb ring finger treatment ISO RGD PMID:26919246 RGD:14928318 NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
JBrowse link
G Bmper BMP-binding endothelial regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:21,732,225...21,977,261
Ensembl chr 8:21,732,225...21,977,256
JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:27222248 NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
JBrowse link
G Bsg basigin (Ok blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:36574092 NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
JBrowse link
G Btg2 BTG anti-proliferation factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18393292 NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
JBrowse link
G Bub1 BUB1 mitotic checkpoint serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
JBrowse link
G Bub1b BUB1 mitotic checkpoint serine/threonine kinase B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
JBrowse link
G C3 complement C3 IEP RGD PMID:23245919 RGD:11040806 NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
JBrowse link
G C6h14orf180 similar to human chromosome 14 open reading frame 180 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:131,557,193...131,568,245
Ensembl chr 6:131,559,690...131,567,342
JBrowse link
G C9 complement C9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 PMID:28284560 NCBI chr 2:55,573,094...55,621,345
Ensembl chr 2:55,572,992...55,621,338
JBrowse link
G Cab39 calcium binding protein 39 disease_progression ISO RGD PMID:28605041 PMID:28605041 RGD:14398832, RGD:14398832 NCBI chr 9:86,463,095...86,524,545
Ensembl chr 9:86,463,095...86,524,544
JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase IEP
IAGP
mRNA:increased expression:liver
DNA:amplification:cds (rat)
RGD PMID:2888462 PMID:2914957 PMID:7053379 RGD:2303530, RGD:5132587, RGD:10755426 NCBI chr 6:25,292,133...25,315,078
Ensembl chr 6:25,292,133...25,319,861
JBrowse link
G Cadm1 cell adhesion molecule 1 IEP DNA, mRNA, protein:hypermethylation, decreased expression:promoter:liver RGD PMID:17428255 RGD:2289095 NCBI chr 8:47,847,836...48,178,703
Ensembl chr 8:47,847,325...48,182,833
JBrowse link
G Cadm2 cell adhesion molecule 2 disease_progression ISO mRNA, protein:decreased expression:liver RGD PMID:24240726 RGD:15092075 NCBI chr11:4,548,367...5,525,420
Ensembl chr11:4,555,159...5,525,400
JBrowse link
G Calml3 calmodulin-like 3 severity ISO protein:decreased expression:liver (human) RGD PMID:29445139 RGD:151665319 NCBI chr17:66,419,844...66,423,083
Ensembl chr17:66,419,882...66,423,175
JBrowse link
G Calr calreticulin exacerbates
treatment
ISO protein:increased expression:liver (human)
human cells and recombinant gene in a mouse model
RGD PMID:27055635 PMID:12096119 PMID:24997628 RGD:150521681, RGD:150521690, RGD:150521691 NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 ISO RGD PMID:23651211 RGD:18337283 NCBI chr 5:150,674,819...150,676,600
Ensembl chr 5:150,673,507...150,676,600
JBrowse link
G Cap2 cyclase associated actin cytoskeleton regulatory protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:18,054,234...18,203,453
Ensembl chr17:18,054,431...18,203,373
JBrowse link
G Capn3 calpain 3 IEP mRNA:decreased expression:skeletal muscle RGD PMID:10806331 RGD:1600777 NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:107,407,850...107,457,858
JBrowse link
G Car12 carbonic anhydrase 12 disease_progression
ameliorates
ISO mRNA:altered expression:liver RGD PMID:35362480 PMID:35362480 PMID:31934040 PMID:29900055 RGD:153352325, RGD:153352325, RGD:153352328, RGD:155226869 NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
JBrowse link
G Car2 carbonic anhydrase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
JBrowse link
G Car9 carbonic anhydrase 9 ISO mRNA:altered expression:liver RGD PMID:29900055 RGD:155226869 NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
JBrowse link
G Carm1 coactivator-associated arginine methyltransferase 1 IEP mRNA,protein:increased expression:liver: RGD PMID:23912631 RGD:9586718 NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689
JBrowse link
G Casp3 caspase 3 treatment IEP RGD PMID:29133031 PMID:33841550 RGD:13782296, RGD:152998960 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Casp8 caspase 8 treatment
severity
ISO
IEP
associated with hepatitis B;DNA:insertion/deletion:promoter: (rs3834129) (human)
CTD Direct Evidence: marker/mechanism
OMIM
CTD
RGD
PMID:29133031 PMID:28643196 RGD:13782296, RGD:14695027 NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
JBrowse link
G Casp9 caspase 9 treatment IEP RGD PMID:29133031 RGD:13782296 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
JBrowse link
G Cat catalase disease_progression ISO associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-262T>C (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:33010264 PMID:21907168 RGD:27095879 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
JBrowse link
G Cbfb core-binding factor subunit beta ISO mRNA:decreased expression:liver RGD PMID:17094378 RGD:126775147 NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
JBrowse link
G Cbl Cbl proto-oncogene disease_progression ISO RGD PMID:26474280 RGD:11536137 NCBI chr 8:44,487,824...44,571,620
Ensembl chr 8:44,489,410...44,571,176
JBrowse link
G Cbr1 carbonyl reductase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21056497 NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393
Ensembl chr11:32,908,950...32,911,393
JBrowse link
G Cbx2 chromobox 2 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr10:104,278,517...104,287,384
Ensembl chr10:104,278,549...104,287,383
JBrowse link
G Cbx4 chromobox 4 disease_progression ISO protein:increased expression:cytoplasm: RGD PMID:24838576 PMID:23943028 RGD:9586738, RGD:9586739 NCBI chr10:104,337,140...104,343,210
Ensembl chr10:104,336,876...104,356,706
JBrowse link
G Cbx7 chromobox 7 ISO mRNA:decreased expression:liver RGD PMID:22041561 RGD:9587355 NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
JBrowse link
G Ccbe1 collagen and calcium binding EGF domains 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:59,579,851...59,823,977
Ensembl chr18:59,580,768...59,824,400
JBrowse link
G Ccdc150 coiled-coil domain containing 150 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr 9:55,793,544...55,897,341
Ensembl chr 9:55,793,551...55,897,224
JBrowse link
G Ccl1 C-C motif chemokine ligand 1 ISO mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr10:67,128,331...67,131,109
Ensembl chr10:67,128,331...67,131,159
JBrowse link
G Ccl12 C-C motif chemokine ligand 12 ISO mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 treatment ISO RNA:increased expression:liver RGD PMID:27980102 PMID:27980102 PMID:12679798 PMID:22402625 RGD:14995459, RGD:14995459, RGD:14995468, RGD:14995927 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16284949 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 treatment
susceptibility
ISO DNA:polymorphisms:promoter:-403G>A,-28C>G (human)
associated with alcoholic liver cirrhosis;DNA:SNP:promoter:-403G>A(human)
RGD PMID:28011329 PMID:22374185 PMID:21610221 RGD:14995306, RGD:14995333, RGD:14995338 NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
JBrowse link
G Ccn1 cellular communication network factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17699798 NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
JBrowse link
G Ccna1 cyclin A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12029619 NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
JBrowse link
G Ccnb1 cyclin B1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
JBrowse link
G Ccnb2 cyclin B2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
JBrowse link
G Ccnd1 cyclin D1 susceptibility ISO CTD Direct Evidence: marker/mechanism
associated with Hepatitis B, Chronic;DNA:SNP:splice-site mutation:870G>A (human)
mRNA:increased expression:liver (mouse)
CTD
RGD
PMID:12029619 PMID:19919837 PMID:22649188 PMID:25822088 PMID:26189965 More... RGD:14401586, RGD:127285675 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
JBrowse link
G Ccnd2 cyclin D2 severity
disease_progression
susceptibility
ISO associated with hepatitis B
DNA:hypermethylation:CpG site
associated with Chronic Hepatitis C;DNA:SNP: :rs1049606(human)
RGD PMID:33320844 PMID:33320844 PMID:31059558 PMID:22004425 RGD:151664743, RGD:151664743, RGD:151665109, RGD:151665169 NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495
JBrowse link
G Ccne1 cyclin E1 ameliorates IEP
ISO
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12029619 PMID:22634754 PMID:17196522 PMID:28100771 PMID:29551768 RGD:2289277, RGD:127285675, RGD:153297807 NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
JBrowse link
G Ccnf cyclin F ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:13,253,073...13,279,140
Ensembl chr10:13,253,380...13,279,101
JBrowse link
G Ccng1 cyclin G1 treatment
disease_progression
severity
IGI
IEP
ISO
protein:increased expression:liver (human)
human cells in mouse model
protein:decreased expression:liver (human)
RGD PMID:25431954 PMID:24034575 PMID:26345095 PMID:23804702 PMID:23804702 More... RGD:151356922, RGD:151356932, RGD:151356933, RGD:151356967, RGD:151356967, RGD:151356970, RGD:151356981, RGD:151361198, RGD:151361200 NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
JBrowse link
G Ccng2 cyclin G2 ISO RGD PMID:27982046 RGD:151361200 NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
JBrowse link
G Ccr1 C-C motif chemokine receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16284949 NCBI chr 8:123,556,286...123,561,841 JBrowse link
G Cd163 CD163 molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
JBrowse link
G Cd274 CD274 molecule disease_progression ISO CTD Direct Evidence: marker/mechanism
associated with hepatitis B
associated with hepatitis B
CTD
RGD
PMID:22396772 PMID:30267213 PMID:21912640 RGD:40818240, RGD:41410800 NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
JBrowse link
G Cd276 Cd276 molecule ISO CTD Direct Evidence: therapeutic CTD PMID:16217749 NCBI chr 8:58,937,751...58,968,082
Ensembl chr 8:58,937,751...58,968,380
JBrowse link
G Cd34 CD34 molecule ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:106,480,313...106,500,844
Ensembl chr13:106,480,043...106,499,832
JBrowse link
G Cd40lg CD40 ligand ISO RGD PMID:19016771 RGD:2313413 NCBI chr  X:135,127,052...135,138,768
Ensembl chr  X:135,126,969...135,138,306
JBrowse link
G Cd5l Cd5 molecule-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
JBrowse link
G Cd68 Cd68 molecule severity ISO protein:increased expression:liver (human) RGD PMID:28656201 RGD:40924686 NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
JBrowse link
G Cdc20 cell division cycle 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
JBrowse link
G Cdc25c cell division cycle 25C ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
JBrowse link
G Cdc27 cell division cycle 27 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr10:89,400,720...89,449,816
Ensembl chr10:89,400,940...89,449,736
JBrowse link
G Cdc45 cell division cycle 45 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619
JBrowse link
G Cdc6 cell division cycle 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011
JBrowse link
G Cdca2 cell division cycle associated 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611
JBrowse link
G Cdca3 cell division cycle associated 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:157,634,775...157,638,799
Ensembl chr 4:157,634,928...157,638,799
JBrowse link
G Cdca5 cell division cycle associated 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023
JBrowse link
G Cdca8 cell division cycle associated 8 disease_progression ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver (human)
CTD
RGD
PMID:28284560 PMID:35693827 RGD:153344586 NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629
JBrowse link
G Cdh1 cadherin 1 severity IDA
ISO
DNA:hypermethylation
mRNA:increased expression:liver
protein:decreased expression:liver
RGD PMID:17295234 PMID:30697077 PMID:30697077 PMID:24840851 PMID:18837082 RGD:2289638, RGD:14402045, RGD:14402045, RGD:14402046, RGD:14402047 NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
JBrowse link
G Cdh13 cadherin 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18425332 PMID:18553387 PMID:28284560 NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
JBrowse link
G Cdk1 cyclin-dependent kinase 1 ISO protein:increased expression:liver (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:28284560 PMID:19136513 RGD:2316317 NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
JBrowse link
G Cdk12 cyclin-dependent kinase 12 exacerbates ISO mRNA, protein:increased expression:liver (human) RGD PMID:31519701 RGD:151361172 NCBI chr10:83,201,177...83,256,906
Ensembl chr10:83,201,211...83,280,888
Ensembl chr10:83,201,211...83,280,888
JBrowse link
G Cdk13 cyclin-dependent kinase 13 onset ISO DNA:amplification: : RGD PMID:22912832 RGD:155641228 NCBI chr17:47,251,145...47,344,675
Ensembl chr17:47,251,163...47,341,721
JBrowse link
G Cdk14 cyclin-dependent kinase 14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22922871 NCBI chr 4:28,666,416...29,258,865
Ensembl chr 4:28,666,843...29,258,861
JBrowse link
G Cdk4 cyclin-dependent kinase 4 treatment ISO
IEP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:26189965 PMID:33841550 RGD:152998960 NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A ISS OMIM:114550 MouseDO NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B ISO CTD Direct Evidence: marker/mechanism CTD PMID:20698225 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C severity ISO protein:decreased expression:liver (human) RGD PMID:26606000 RGD:11354707 NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
JBrowse link
G Cdkn2a cyclin-dependent kinase inhibitor 2A severity IEP
IDA
ISO
Protein:increased expression:liver
DNA:hypermethylation:promoter
DNA:hypermethylation:exon
Protein:decreased expression:liver
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
RGD
CTD
ClinVar
PMID:7780957 PMID:8521414 PMID:9185756 PMID:9324288 PMID:10491434 More... RGD:1600816, RGD:1600816, RGD:1600822, RGD:8552680 NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
JBrowse link
G Cdkn2a_v1 cyclin-dependent kinase inhibitor 2A, variant 1 IEP Protein:decreased expression:liver RGD PMID:16317707 RGD:1600816
G Cdkn2b cyclin-dependent kinase inhibitor 2B ISO CTD Direct Evidence: marker/mechanism CTD PMID:33010264 NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
JBrowse link
G Cdkn2c cyclin-dependent kinase inhibitor 2C ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 severity
treatment
ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver
protein:decreased expression:liver
associated with alcoholism; protein:increased expression:liver
CTD
RGD
PMID:28284560 PMID:22390936 PMID:27314282 PMID:23292002 PMID:23292002 RGD:15090800, RGD:15090801, RGD:15090802, RGD:15090802 NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945
JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:16288022 PMID:21785164 NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
JBrowse link
G Cebpb CCAAT/enhancer binding protein beta ISO CTD Direct Evidence: marker/mechanism
mRNA: increased expression:liver (human)
CTD
RGD
PMID:14563831 PMID:30659195 RGD:40903042 NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
JBrowse link
G Cebpd CCAAT/enhancer binding protein delta ISO CTD Direct Evidence: marker/mechanism CTD PMID:14563831 NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354
JBrowse link
G Cenpa centromere protein A ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)
CTD
RGD
PMID:28284560 PMID:21956590 RGD:36947377 NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
JBrowse link
G Cenpe centromere protein E ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
JBrowse link
G Cenpf centromere protein F ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669
JBrowse link
G Cenpm centromere protein M ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:113,748,026...113,759,296
Ensembl chr 7:113,747,516...113,764,258
JBrowse link
G Cenpu centromere protein U ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:45,715,821...45,739,038
Ensembl chr16:45,714,294...45,738,823
JBrowse link
G Cenpw centromere protein W ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:27,525,324...27,530,464
JBrowse link
G Cep131 centrosomal protein 131 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:105,346,015...105,370,380
Ensembl chr10:105,346,015...105,370,380
JBrowse link
G Cep164 centrosomal protein 164 susceptibility ISO associated with Chronic Hepatitis C;DNA:SNP: :rs573455 (human) RGD PMID:22004425 RGD:151665169 NCBI chr 8:46,070,901...46,134,511
Ensembl chr 8:46,071,076...46,134,336
JBrowse link
G Cep55 centrosomal protein 55 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:235,832,823...235,848,401
Ensembl chr 1:235,832,878...235,848,394
JBrowse link
G Ces1d carboxylesterase 1D disease_progression ISO protein:decreased expression:liver (human)
mRNA, protein:decreased expression:liver tumor (human)
associated with tumor vascularization; protein:decreased expression:liver tumor (human)
RGD PMID:24259486 PMID:19658107 PMID:30901224 RGD:152995276, RGD:152995279, RGD:152995286 NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
JBrowse link
G Cfp complement factor properdin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:1,162,014...1,167,576
Ensembl chr  X:1,161,979...1,167,573
JBrowse link
G Chaf1b chromatin assembly factor 1 subunit B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070
JBrowse link
G Chd4 chromodomain helicase DNA binding protein 4 exacerbates ISO mRNA:increased expression:liver (human)
protein:increased expression:liver (human)
RGD PMID:28486105 PMID:26095183 RGD:153323299, RGD:11571740 NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
JBrowse link
G Chd5 chromodomain helicase DNA binding protein 5 ISO mRNA:decreased expression:liver RGD PMID:26517514 RGD:11537550 NCBI chr 5:162,848,273...162,898,997
Ensembl chr 5:162,848,394...162,896,291
JBrowse link
G Ckap2l cytoskeleton associated protein 2-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:116,497,186...116,524,302
Ensembl chr 3:116,498,022...116,524,366
JBrowse link
G Ckap4 cytoskeleton-associated protein 4 disease_progression ISO associated with tumor vascularization; mRNA,protein:increased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914
JBrowse link
G Cldn1 claudin 1 severity IEP protein:increased expression:liver (human)
protein:decreased expression:liver (human)
associated with liver cirrhosis;protein:increased expression:liver (human)
RGD PMID:24815833 PMID:17270214 PMID:24696415 RGD:26884345, RGD:26884348, RGD:26884352 NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
JBrowse link
G Clec1b C-type lectin domain family 1, member B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:162,847,978...162,856,291
Ensembl chr 4:162,848,010...162,856,291
JBrowse link
G Clec4g C-type lectin domain family 4, member G ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr12:1,780,370...1,785,027
Ensembl chr12:1,780,371...1,784,985
JBrowse link
G Clec4m C-type lectin domain family 4 member M ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr12:1,915,902...1,924,529
Ensembl chr12:1,915,919...1,924,539
JBrowse link
G Clptm1l CLPTM1-like susceptibility
disease_progression
ISO DNA:SNPs::rs401681(human)
DNA:SNP: :rs401681(human)
RGD PMID:25339005 PMID:29042796 RGD:150530496, RGD:150537100 NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
JBrowse link
G Cltrn collectrin, amino acid transport regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:30,361,967...30,395,264
Ensembl chr  X:30,361,967...30,395,349
JBrowse link
G Cndp1 carnosine dipeptidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
JBrowse link
G Cnot9 CCR4-NOT transcription complex subunit 9 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:26619011 NCBI chr 9:76,084,269...76,109,111
Ensembl chr 9:76,084,334...76,109,100
JBrowse link
G Cntnap4 contactin associated protein family member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:40,568,684...40,861,879
Ensembl chr19:40,568,684...40,854,656
JBrowse link
G Col15a1 collagen type XV alpha 1 chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:61,501,963...61,607,591
Ensembl chr 5:61,501,963...61,607,591
JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain severity IDA Protein:increased expression RGD PMID:15739185 RGD:1600906 NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
JBrowse link
G Colec10 collectin subfamily member 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:85,744,895...85,806,368
Ensembl chr 7:85,744,895...85,805,675
JBrowse link
G Comt catechol-O-methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15341023 NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
JBrowse link
G Cops5 COP9 signalosome subunit 5 severity ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)
CTD
RGD
PMID:20698225 PMID:26606000 RGD:11354707 NCBI chr 5:9,192,233...9,210,498
Ensembl chr 5:9,192,100...9,210,731
JBrowse link
G Cox7b2 cytochrome c oxidase subunit 7B2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr14:36,693,120...36,805,323
Ensembl chr14:36,693,105...36,805,523
JBrowse link
G Cp ceruloplasmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:19229483 NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
JBrowse link
G Cpeb3 cytoplasmic polyadenylation element binding protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
JBrowse link
G Cps1 carbamoyl-phosphate synthase 1 disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr 9:68,614,153...68,737,037
Ensembl chr 9:68,614,153...68,737,033
JBrowse link
G Crebbp CREB binding protein ISO ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: LIVER CELL CARCINOMA ClinVar PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 More... NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
JBrowse link
G Crhbp corticotropin releasing hormone binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:26,692,403...26,704,710
Ensembl chr 2:26,692,403...26,704,710
JBrowse link
G Crp C-reactive protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
JBrowse link
G Csf1r colony stimulating factor 1 receptor severity
exacerbates
ISO DNA:hypomethylation:promoter (human)
protein:increased expression: liver (human)
protein:increased expression:liver (human)
RGD PMID:32724427 PMID:32760707 PMID:11412385 PMID:14969845 RGD:150524282, RGD:150524286, RGD:150524301, RGD:150524302 NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
JBrowse link
G Csf2 colony stimulating factor 2 treatment ISO RGD PMID:12731087 RGD:10450243 NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
JBrowse link
G Csk C-terminal Src kinase IEP protein:decreased expression:liver RGD PMID:9918913 RGD:5134372 NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:72,218,189...73,818,380
Ensembl chr16:72,218,503...73,817,614
JBrowse link
G Cspg4 chondroitin sulfate proteoglycan 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:57,264,962...57,300,010
Ensembl chr 8:57,264,962...57,300,010
JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
JBrowse link
G Ctla4 cytotoxic T-lymphocyte-associated protein 4 susceptibility ISO protein:increased expression:CD4+ and CD8+ T cells:
DNA:SNPs: :rs231775,rs231725(human)
RGD PMID:28648905 PMID:23432218 RGD:14398741, RGD:14398742 NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
JBrowse link
G Ctnnb1 catenin beta 1 susceptibility
severity
exacerbates
ISO DNA:mutation:exon 3
CTD Direct Evidence: marker/mechanism
associated with Hepatitis B, Chronic,DNA:SNP, haplotype: :rs3864004 (human)
associated with hepatitis B;DNA:SNPs: :rs3864004,rs11564475(human)
protein:increased expression:liver:
DNA:Mutations:exon:
DNA:missense mutations:exon 3:multiple (human)
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA
OMIM
CTD
ClinVar
RGD
PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 More... RGD:734850, RGD:14402039, RGD:14402040, RGD:14402052, RGD:14402052, RGD:150429592 NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
JBrowse link
G Ctsb cathepsin B IDA RGD PMID:15641152 RGD:2315605 NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
JBrowse link
G Ctsd cathepsin D ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
JBrowse link
G Ctsl cathepsin L IDA RGD PMID:15641152 RGD:2315605 NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
JBrowse link
G Cux1 cut-like homeobox 1 ISO mRNA:increased expression:liver (human) RGD PMID:30561038 RGD:152985541 NCBI chr12:20,107,062...20,425,868
Ensembl chr12:20,107,311...20,425,866
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 disease_progression
treatment
ISO RGD PMID:28592115 PMID:28638480 PMID:27245433 RGD:27095889, RGD:27095898, RGD:27095899 NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
JBrowse link
G Cxcl11 C-X-C motif chemokine ligand 11 ISO mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 PMID:28284560 NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839
JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 treatment
severity
ISO human cells in mouse model
protein:increased expression:liver (human)
RGD PMID:30034941 PMID:33574707 RGD:151665331, RGD:151665327 NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
JBrowse link
G Cyld CYLD lysine 63 deubiquitinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21109933 NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15341023 NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15341023 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 susceptibility ISO associated with hepatitis C; DNA:polymorphisms: : RGD PMID:11021356 RGD:124713413 NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism
associated with alcohol dependence
DNA, mRNA:SNP, Decreased expression:liver: rs2031920 (human)
CTD
RGD
PMID:15162526 PMID:20364586 PMID:29765251 RGD:14700882, RGD:14700899 NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
JBrowse link
G Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775
JBrowse link
G Dab2ip DAB2 interacting protein severity ISO mRNA:decreased expression:liver (human)
protein:decreased expression:liver (human)
RGD PMID:31176165 PMID:22168621 RGD:151665110, RGD:151665148 NCBI chr 3:18,915,290...19,086,282
Ensembl chr 3:18,915,290...19,086,280
JBrowse link
G Dbh dopamine beta-hydroxylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:10,488,260...10,505,245
Ensembl chr 3:10,488,260...10,505,248
JBrowse link
G Dcn decorin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
JBrowse link
G Ddr1 discoidin domain receptor tyrosine kinase 1 severity ISO mRNA:increased expression:liver (human) RGD PMID:33173221 PMID:33173221 RGD:151347691, RGD:151347691 NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468
JBrowse link
G Ddr2 discoidin domain receptor tyrosine kinase 2 treatment
disease_progression
ISO RGD PMID:33969575 PMID:26362312 RGD:150429748, RGD:11086753 NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
JBrowse link
G Ddx3x DEAD-box helicase 3, X-linked exacerbates
sexual_dimorphism
ISO associated with hepatitis B; mRNA,protein:decreased expression:liver (human) RGD PMID:30297359 PMID:16301996 RGD:151356499, RGD:151356660 NCBI chr  X:9,479,532...9,493,169
Ensembl chr  X:9,479,532...9,493,168
JBrowse link
G Depdc1 DEP domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:248,684,508...248,717,951
Ensembl chr 2:248,684,523...248,717,951
JBrowse link
G Depdc1b DEP domain containing 1B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:39,891,163...39,963,779
Ensembl chr 2:39,891,481...39,963,779
JBrowse link
G Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:21725309 NCBI chr14:77,732,297...77,862,924
Ensembl chr14:77,732,297...77,862,794
JBrowse link
G Dhfr dihydrofolate reductase ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:28492532 NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713
JBrowse link
G Dicer1 dicer 1 ribonuclease III susceptibility ISO associated with hepatitis B; DNA:SNP: :rs1057035 T>C (human) RGD PMID:23868705 RGD:149735346 NCBI chr 6:123,627,529...123,692,278
Ensembl chr 6:123,631,250...123,693,965
JBrowse link
G Dipk2b divergent protein kinase domain 2B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:4,205,486...4,274,939
Ensembl chr  X:4,205,490...4,271,574
JBrowse link
G Diras3 DIRAS family GTPase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:130,524,972...130,526,186
Ensembl chr 6:130,524,742...130,530,825
JBrowse link
G Dlgap5 DLG associated protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr15:20,633,964...20,664,569
Ensembl chr15:20,633,966...20,664,518
JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 ISO mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
JBrowse link
G Dmgdh dimethylglycine dehydrogenase disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
JBrowse link
G Dnajc6 DnaJ heat shock protein family (Hsp40) member C6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:116,120,069...116,283,448
Ensembl chr 5:116,119,676...116,283,448
JBrowse link
G Dnase1l3 deoxyribonuclease 1-like 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
JBrowse link
G Dnmt1 DNA methyltransferase 1 IEP mRNA, protein:increased expression:liver RGD PMID:11844796 RGD:2289670 NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha ISO
IEP
protein:increased expression:liver:
mRNA, protein:increased expression:liver
RGD PMID:15885882 PMID:11844796 RGD:9588598, RGD:2289670 NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
JBrowse link
G Dnmt3b DNA methyltransferase 3 beta ISO
IEP
mRNA:increased expression:liver:
mRNA, protein:increased expression:liver
RGD PMID:15885882 PMID:11844796 RGD:9588598, RGD:2289670 NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
JBrowse link
G Dpyd dihydropyrimidine dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:18019677 NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
JBrowse link
G Drd4 dopamine receptor D4 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553
JBrowse link
G Dsn1 DSN1 component of MIS12 kinetochore complex disease_progression ISO RGD PMID:30136646 RGD:27372884 NCBI chr 3:145,652,741...145,668,025
Ensembl chr 3:145,652,737...145,665,856
JBrowse link
G Dspp dentin sialophosphoprotein ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr14:5,565,562...5,571,669
Ensembl chr14:5,565,629...5,571,672
JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase homolog ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
JBrowse link
G Dynlrb1 dynein light chain roadblock-type 1 ISO RGD PMID:11750132 RGD:13208527 NCBI chr 3:143,742,427...143,764,227
Ensembl chr 3:143,742,586...143,764,227
JBrowse link
G Dynlrb2 dynein light chain roadblock-type 2 ISO RGD PMID:11750132 RGD:13208527 NCBI chr19:44,520,134...44,531,384
Ensembl chr19:44,520,134...44,531,387
JBrowse link
G E2f1 E2F transcription factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12029619 PMID:15565109 PMID:28284560 NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
JBrowse link
G E2f8 E2F transcription factor 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098
JBrowse link
G Eaf2 ELL associated factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20564326 NCBI chr11:63,960,200...64,004,610
Ensembl chr11:63,960,200...64,004,610
JBrowse link
G Ecm1 extracellular matrix protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:183,287,491...183,292,729
Ensembl chr 2:183,287,322...183,292,671
JBrowse link
G Ect2 epithelial cell transforming 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:109,975,813...110,037,911
Ensembl chr 2:109,975,813...110,037,911
JBrowse link
G Eef2 eukaryotic translation elongation factor 2 exacerbates ISO protein:increased expression, increased phosphorylation:liver (human) RGD PMID:28060762 RGD:153298915 NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183
JBrowse link
G Efemp1 EGF containing fibulin extracellular matrix protein 1 disease_progression ISO protein:decreased expression:liver: RGD PMID:23936443 RGD:10401793 NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
JBrowse link
G Eftud2 elongation factor Tu GTP binding domain containing 2 severity
ameliorates
ISO RGD PMID:34282556 PMID:34282556 RGD:155791664, RGD:155791664 NCBI chr10:87,804,893...87,852,181
Ensembl chr10:87,804,892...87,846,079
JBrowse link
G Egf epidermal growth factor susceptibility ISO CTD Direct Evidence: marker/mechanism
associated with liver cirrhosis;DNA:SNP:5'UTR: (rs4444903) (human)
associated with hepatitis B;DNA:SNP:exon: (rs11569017) (human)
CTD
RGD
PMID:9029167 PMID:18167406 PMID:23790025 RGD:14695013, RGD:14695014 NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
JBrowse link
G Egfr epidermal growth factor receptor disease_progression ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:9029167 PMID:11355950 RGD:126781769 NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
JBrowse link
G Egr1 early growth response 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
JBrowse link
G Egr2 early growth response 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562
JBrowse link
G Ehd3 EH-domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:21,640,861...21,665,601
Ensembl chr 6:21,639,290...21,665,236
JBrowse link
G Eif3h eukaryotic translation initiation factor 3, subunit H ISO CTD Direct Evidence: marker/mechanism CTD PMID:14578863 NCBI chr 7:83,091,037...83,174,451
Ensembl chr 7:83,091,039...83,174,451
JBrowse link
G Enah ENAH, actin regulator disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35030977 RGD:155791678 NCBI chr13:93,617,747...93,738,119
Ensembl chr13:93,626,944...93,740,955
JBrowse link
G Eng endoglin IEP protein:increased expression:liver (rat) RGD PMID:20368095 RGD:7257538 NCBI chr 3:15,934,566...15,972,618
Ensembl chr 3:15,934,518...15,973,230
JBrowse link
G Eno1 enolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336
JBrowse link
G Ep300 E1A binding protein p300 IEP protein:increased expression:liver (rat) RGD PMID:17083329 RGD:2312274 NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088
JBrowse link
G Epas1 endothelial PAS domain protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26735578 NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
JBrowse link
G Epcam epithelial cell adhesion molecule severity ISO protein:increased expression:liver RGD PMID:24616575 RGD:14695007 NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
JBrowse link
G Ephb1 Eph receptor B1 ISO protein:increased phosphorylation:liver (mouse) RGD PMID:28100771 RGD:127285675 NCBI chr 8:102,507,549...102,944,839
Ensembl chr 8:102,507,549...102,944,839
JBrowse link
G Ephx1 epoxide hydrolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:7892276 NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
JBrowse link
G Epo erythropoietin disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
JBrowse link
G Eps8l3 EPS8 like 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:195,514,692...195,528,085
Ensembl chr 2:195,514,692...195,528,085
JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 disease_progression ISO RGD PMID:11355950 RGD:126781769 NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525
JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 ISO DNA:insertion/deletion:3'UTR:rs6147150 (human) RGD PMID:22294845 RGD:126781763 NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
JBrowse link
G Ercc1 ERCC excision repair 1, endonuclease non-catalytic subunit ISO mRNA, protein:increased expression:liver (human) RGD PMID:15922480 RGD:155598683 NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
JBrowse link
G Ercc2 ERCC excision repair 2, TFIIH core complex helicase subunit susceptibility
disease_progression
ISO DNA:SNPs:exon 23: p.K751Q (human)
DNA:SNPs:exon 23: p.K751Q (human)
DNA:SNPs:exon 23: p.K751Q (rs13181) (human)
DNA:SNP:cd: 312A>G (human)
RGD PMID:19919686 PMID:25531380 PMID:28598207 PMID:28927037 RGD:25671459, RGD:25671460, RGD:25671461, RGD:150530503 NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
JBrowse link
G Ereg epiregulin ISO CTD Direct Evidence: marker/mechanism CTD PMID:35776891 NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 ISO DNA:hypomethylation: CpG islands: RGD PMID:20165882 RGD:14694974 NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
JBrowse link
G Erp29 endoplasmic reticulum protein 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr12:35,089,698...35,095,952
Ensembl chr12:35,089,707...35,096,376
JBrowse link
G Esm1 endothelial cell-specific molecule 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804
JBrowse link
G Esr1 estrogen receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 PMID:28284560 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
JBrowse link
G Etfa electron transfer flavoprotein subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
JBrowse link
G Exo1 exonuclease 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654
JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit susceptibility ISO mRNA:increased expression:liver (human)
DNA:SNPs: :multiple
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:28284560 PMID:34545456 PMID:24211739 PMID:26517514 PMID:24040354 More... RGD:10755339, RGD:11537550, RGD:126779595, RGD:126779608 NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
JBrowse link
G F2 coagulation factor II, thrombin severity ISO CTD Direct Evidence: marker/mechanism
associated with liver cirrhosis;protein:altered expression, altered processing:liver (human)
CTD
RGD
PMID:2821104 PMID:7620113 RGD:14975114 NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
JBrowse link
G Fabp5 fatty acid binding protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:91,765,056...91,853,773
JBrowse link
G Fam180a family with sequence similarity 180, member A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:63,992,867...64,008,047
Ensembl chr 4:63,992,867...64,008,047
JBrowse link
G Fam83d family with sequence similarity 83, member D ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192
JBrowse link
G Fancd2 FA complementation group D2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
JBrowse link
G Fanci FA complementation group I ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:133,327,264...133,383,661
Ensembl chr 1:133,327,297...133,383,640
JBrowse link
G Fas Fas cell surface death receptor treatment IEP
ISO
protein:increased expression:liver: RGD PMID:29634416 PMID:11274632 PMID:30737368 RGD:13792608, RGD:14700677, RGD:14700700 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
JBrowse link
G Faslg Fas ligand ISO protein:increased expression:liver: RGD PMID:11274632 RGD:14700677 NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
JBrowse link
G Fasn fatty acid synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:14563831 PMID:15543204 PMID:21147110 NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
JBrowse link
G Fat1 FAT atypical cadherin 1 disease_progression ISO mRNA,protein:increased expression:liver (human) RGD PMID:24590895 RGD:151347630 NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
JBrowse link
G Fbp1 fructose-bisphosphatase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22039417 NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
JBrowse link
G Fbxl18 F-box and leucine-rich repeat protein 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr12:11,674,538...11,701,317
Ensembl chr12:11,676,115...11,699,181
JBrowse link
G Fbxo11 F-box protein 11 exacerbates
ameliorates
ISO mRNA:increased expression:liver (human) RGD PMID:32657545 PMID:29518611 RGD:152025263, RGD:152025259 NCBI chr 6:6,486,761...6,562,664
Ensembl chr 6:6,486,015...6,562,662
JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
JBrowse link
G Fes FES proto-oncogene, tyrosine kinase exacerbates ISO DNA:hypermethylation:promoter (human) RGD PMID:31038805 RGD:153323297 NCBI chr 1:134,337,698...134,346,934
Ensembl chr 1:134,337,698...134,346,934
JBrowse link
G Fga fibrinogen alpha chain ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
JBrowse link
G Fgf19 fibroblast growth factor 19 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25822088 NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
JBrowse link
G Fgf3 fibroblast growth factor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25822088 NCBI chr 1:200,001,162...200,005,539
Ensembl chr 1:200,001,261...200,005,187
JBrowse link
G Fgf4 fibroblast growth factor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25822088 NCBI chr 1:200,023,937...200,027,793
Ensembl chr 1:200,024,056...200,025,466
JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 treatment ISO ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
RGD
PMID:25705862 PMID:26619011 PMID:26942290 PMID:33448156 PMID:36029209 More... RGD:25330358, RGD:25440476, RGD:25440478 NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
JBrowse link
G Fgfr2 fibroblast growth factor receptor 2 severity ISO associated with hepatitis B;DNA:SNPs: promoter, intron:rs308379, rs1219648 (human) RGD PMID:30952770 RGD:38501096 NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
JBrowse link
G Fgfr4 fibroblast growth factor receptor 4 treatment ISO RGD PMID:32677805 RGD:150520166 NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
JBrowse link
G Fh fumarate hydratase ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:10896297 PMID:15221078 PMID:16876016 PMID:17182618 PMID:18313410 More... NCBI chr13:87,524,331...87,550,215
Ensembl chr13:87,524,337...87,550,266
JBrowse link
G Fhit fragile histidine triad diadenosine triphosphatase IDA RGD PMID:12112319 RGD:632723 NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
JBrowse link
G Flt3 Fms related receptor tyrosine kinase 3 ameliorates ISO human cells in mouse model RGD PMID:27511526 RGD:149735514 NCBI chr12:7,623,930...7,699,474
Ensembl chr12:7,623,930...7,699,474
JBrowse link
G Flvcr1 FLVCR choline and heme transporter 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:102,586,263...102,608,647
Ensembl chr13:102,586,257...102,608,661
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:9029167 PMID:28284560 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465
JBrowse link
G Fosl2 FOS like 2, AP-1 transcription factor subunit ISO mRNA:increased expression:liver (human) RGD PMID:30086463 PMID:32048611 RGD:153344517, RGD:153344521 NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
JBrowse link
G Foxa1 forkhead box A1 susceptibility
disease_progression
sexual_dimorphism
ISO DNA:VNTR, SNPs, haplotypes:multiple:
protein:decreased expression:liver
RGD PMID:29208003 PMID:31400761 PMID:25965836 RGD:151665820, RGD:151665752, RGD:11054501 NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
JBrowse link
G Foxm1 forkhead box M1 ISO
ISS
CTD Direct Evidence: marker/mechanism
OMIM:114550
CTD
MouseDO
PMID:15082532 PMID:17173139 PMID:28284560 NCBI chr 4:161,639,538...161,652,012
Ensembl chr 4:161,638,816...161,650,684
JBrowse link
G Foxo1 forkhead box O1 ISO mRNA:decreased expression:liver RGD PMID:28972178 RGD:14401599 NCBI chr 2:136,312,168...136,390,603
Ensembl chr 2:136,312,168...136,387,790
JBrowse link
G Foxp1 forkhead box P1 treatment IEP RGD PMID:25156538 RGD:9587823 NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
JBrowse link
G Foxp3 forkhead box P3 ISO protein:increased expression:liver RGD PMID:21086571 RGD:38548919 NCBI chr  X:14,908,494...14,924,994
Ensembl chr  X:14,908,494...14,923,838
JBrowse link
G Fst follistatin ISO CTD Direct Evidence: marker/mechanism CTD PMID:12203361 PMID:19363144 NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
JBrowse link
G Fth1 ferritin heavy chain 1 IEP mRNA:increased expression:liver (rat) RGD PMID:9054589 RGD:632698 NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
JBrowse link
G Fubp1 far upstream element binding protein 1 exacerbates
ameliorates
ISO mRNA:increased expression:liver (human)
human cell line in a mouse model
associated with Chronic Hepatitis C;mRNA:increased expression:liver (human)
RGD PMID:31587040 PMID:19637194 PMID:25995247 RGD:151361188, RGD:151361194, RGD:151361196 NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 treatment ISO associated with Glycogen Storage Disease IA, human gene in a mouse model RGD PMID:28096054 RGD:14695537 NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
JBrowse link
G G6pd glucose-6-phosphate dehydrogenase disease_progression IEP
ISO
mRNA:increased expression:liver (human) RGD PMID:25473368 PMID:35693827 RGD:10449118, RGD:153344586 NCBI chr  X:152,201,081...152,220,863
Ensembl chr  X:152,201,098...152,220,801
JBrowse link
G Gabrd gamma-aminobutyric acid type A receptor subunit delta ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:165,958,508...165,970,407
Ensembl chr 5:165,958,484...165,970,411
JBrowse link
G Gabre gamma-aminobutyric acid type A receptor subunit epsilon ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr  X:150,060,035...150,078,773
Ensembl chr  X:150,060,040...150,078,693
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16767786 PMID:21472284 NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
JBrowse link
G Gba3 glucosylceramidase beta 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr14:60,574,974...60,721,411
Ensembl chr14:60,574,976...60,721,653
JBrowse link
G Gc GC, vitamin D binding protein susceptibility IEP
ISO
protein:increased expression:liver
associated with Hepatitis B, Chronic;DNA:SNP: :rs7041(human)
RGD PMID:21683810 PMID:25541958 RGD:5509919, RGD:14402025 NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567
JBrowse link
G Gdf15 growth differentiation factor 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20512989 NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
JBrowse link
G Gdf2 growth differentiation factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23936038 PMID:28284560 NCBI chr16:9,255,430...9,261,429
Ensembl chr16:9,255,430...9,261,429
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 disease_progression ISO HBV associated
RNA,protein:increased expression, activity:liver:
RGD PMID:11940314 PMID:27793641 PMID:10572675 RGD:14701040, RGD:14701041, RGD:14701048 NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
JBrowse link
G Ghr growth hormone receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
JBrowse link
G Gins1 GINS complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:139,724,513...139,745,930
Ensembl chr 3:139,724,490...139,745,936
JBrowse link
G Gjb1 gap junction protein, beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17978847 NCBI chr  X:66,501,848...66,509,783
Ensembl chr  X:66,501,820...66,509,925
JBrowse link
G Gjb2 gap junction protein, beta 2 IDA DNA, mRNA:promoter hypermethylation, decreased expression:liver RGD PMID:17295234 RGD:2289638 NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
JBrowse link
G Gli1 GLI family zinc finger 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26189965 NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
JBrowse link
G Glul glutamate-ammonia ligase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
JBrowse link
G Gmnn geminin, DNA replication inhibitor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054
JBrowse link
G Gmps guanine monophosphate synthase IEP protein:increased activity:hepatoma (rat) RGD PMID:6861338 RGD:5135537 NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875
JBrowse link
G Gnao1 G protein subunit alpha o1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493
JBrowse link
G Gnas GNAS complex locus ISO ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 More... NCBI chr 3:163,071,003...163,136,350
Ensembl chr 3:163,071,417...163,127,262
Ensembl chr 3:163,071,417...163,127,262
JBrowse link
G Gnaz G protein subunit alpha z ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr20:13,643,473...13,694,240
Ensembl chr20:13,644,640...13,669,907
JBrowse link
G Gnmt glycine N-methyltransferase ISO
ISS
CTD Direct Evidence: marker/mechanism
OMIM:114550
CTD
MouseDO
PMID:19146867 PMID:31086990 NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
JBrowse link
G Golm1 golgi membrane protein 1 severity ISO protein:increased expression:serum
mRNA, protein:increased expression:liver
RGD PMID:21140449 PMID:21443671 RGD:401827118, RGD:401827119 NCBI chr17:4,995,925...5,044,329
Ensembl chr17:4,996,104...5,034,057
JBrowse link
G Gpc1 glypican 1 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 9:93,396,234...93,424,047
Ensembl chr 9:93,396,234...93,424,047
JBrowse link
G Gpc3 glypican 3 severity
treatment
disease_progression
exacerbates
ISO
IMP
CTD Direct Evidence: marker/mechanism
protein:increased expression:liver
protein:increased expression:serum
mRNA:increased expression:Peripheral Blood (human)
mRNA,protein:increased expression:peripheral blood mononuclear cell,blood serum, liver (human)
protein:increased expression:blood serum (human)
protein:increased expression:liver (human)
CTD
RGD
PMID:16698587 PMID:27286460 PMID:28284560 PMID:19496787 PMID:25449037 More... RGD:243065134, RGD:14695019, RGD:14695020, RGD:14695020, RGD:243065125, RGD:243065131, RGD:243065135, RGD:243065139 NCBI chr  X:131,868,986...132,236,824
Ensembl chr  X:131,868,990...132,236,798
JBrowse link
G Gpm6a glycoprotein m6a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:36,641,282...36,973,377
Ensembl chr16:36,641,284...36,973,475
JBrowse link
G Gpr158 G protein-coupled receptor 158 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:83,777,625...84,244,428
Ensembl chr17:83,834,569...84,244,428
JBrowse link
G Gpr182 G protein-coupled receptor 182 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:63,585,997...63,589,088
Ensembl chr 7:63,578,750...63,589,210
JBrowse link
G Gpx1 glutathione peroxidase 1 severity
susceptibility
no_association
ISO associated with hepatitis C;DNA:missense mutation:CDS:p.P198L (rs1050450) (human)
associated with alcoholic liver cirrhosis;DNA:missense mutation:CDS:p.P198L (human)
RGD PMID:26990426 PMID:16510607 PMID:19929244 PMID:25894370 RGD:11533013, RGD:151708729, RGD:152995483, RGD:152998906 NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
JBrowse link
G Gpx3 glutathione peroxidase 3 severity
disease_progression
ISO mRNA,protein:decreased expression:liver, blood plasma (human)
DNA:hypermethylation
RGD PMID:25333265 PMID:25445749 RGD:151665355, RGD:151665509 NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
JBrowse link
G Grb7 growth factor receptor bound protein 7 exacerbates ISO protein:increased expression:liver (human) RGD PMID:17634422 RGD:151347655 NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
JBrowse link
G Gstm1 glutathione S-transferase mu 1 susceptibility
no_association
ISO DNA:deletion:cds (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:7892276 PMID:11859714 PMID:20683151 PMID:20672314 RGD:7488953, RGD:14700951, RGD:14700979 NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
JBrowse link
G Gstp1 glutathione S-transferase pi 1 ISO CTD Direct Evidence: marker/mechanism
DNA:increased methylation:promoter
CTD
RGD
PMID:9029167 PMID:22536438 RGD:14401712 NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
JBrowse link
G Gstt1 glutathione S-transferase theta 1 susceptibility
no_association
ISO DNA:deletion RGD PMID:23053942 PMID:20683151 PMID:20672314 RGD:14401714, RGD:14700951, RGD:14700979 NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
JBrowse link
G Gtse1 G-2 and S-phase expressed 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806
JBrowse link
G Gys2 glycogen synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
JBrowse link
G H19 H19 imprinted maternally expressed transcript IEP mRNA:increased expression:liver RGD PMID:17393425 RGD:2306187 NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
JBrowse link
G Hamp hepcidin antimicrobial peptide ISO
IEP
IDA
CTD Direct Evidence: marker/mechanism
mRNA:decreased expression:liver (human)
DNA:hypermethylation,hypomethylation:promoter
CTD
RGD
PMID:28284560 PMID:29235098 PMID:29235098 RGD:15042879, RGD:15042879 NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891
JBrowse link
G Hao2 hydroxyacid oxidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
JBrowse link
G Havcr2 hepatitis A virus cellular receptor 2 disease_progression ISO associated with hepatitis B;DNA:SNP: : ���1516 G>T (human) RGD PMID:27034168 RGD:40818257 NCBI chr10:30,882,484...30,914,018
Ensembl chr10:30,882,606...30,909,137
JBrowse link
G Hdac2 histone deacetylase 2 disease_progression ISO mRNA:increased expression:liver: RGD PMID:24448241 RGD:9590206 NCBI chr20:40,548,244...40,571,609
Ensembl chr20:40,548,250...40,571,609
JBrowse link
G Hdac4 histone deacetylase 4 ISO mRNA:increased expression:liver: RGD PMID:21837748 RGD:9681451 NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
JBrowse link
G Hfe homeostatic iron regulator disease_progression ISO associated with Liver Cirrhosis;DNA:missense mutation:cds:p.C282Y (human) RGD PMID:20019189 PMID:29642405 RGD:2317357, RGD:14746967 NCBI chr17:41,413,451...41,421,502
Ensembl chr17:41,413,451...41,421,502
JBrowse link
G Hgf hepatocyte growth factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9932610 PMID:11896611 NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
JBrowse link
G Hgfac HGF activator ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr14:75,707,588...75,714,182
Ensembl chr14:75,707,591...75,714,278
JBrowse link
G Hhip Hedgehog-interacting protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:18559595 NCBI chr19:27,863,684...27,952,528
Ensembl chr19:27,863,213...27,952,528
JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha treatment
disease_progression
IMP
ISO
protein:increased expression:liver (human) RGD PMID:19335982 PMID:26078356 PMID:31321740 RGD:9068886, RGD:11526468, RGD:155882550 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
JBrowse link
G Hilpda hypoxia inducible lipid droplet-associated disease_progression ISO mRNA, protein:increased expression:liver (human)
human cells in mouse model
mRNA:increased expression:liver (human)
RGD PMID:31142329 PMID:31142329 PMID:30205391 PMID:35693827 RGD:153344574, RGD:153344574, RGD:153344577, RGD:153344586 NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
JBrowse link
G Hjurp Holliday junction recognition protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:88,853,379...88,867,730
Ensembl chr 9:88,853,386...88,867,728
JBrowse link
G Hmgb2 high mobility group box 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20851854 NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:9207284 PMID:21147110 NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 disease_progression ISO RGD PMID:28867541 RGD:14975299 NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130
JBrowse link
G Hmmr hyaluronan-mediated motility receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
JBrowse link
G Hnf1a HNF1 homeobox A treatment IMP human cell line in mouse model RGD PMID:29466992 RGD:14700664 NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha IEP
ISO
protein:decreased expression:liver: RGD PMID:20876809 PMID:20876809 RGD:12904747, RGD:12904747 NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
JBrowse link
G Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 ISO protein:increased expression:liver (human) RGD PMID:23633480 RGD:9685423 NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 ISO
IEP
protein:increased expression:liver (human)
mRNA:increased expression:liver (rat)
RGD PMID:20604928 PMID:23633480 RGD:9685422, RGD:9685423 NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
JBrowse link
G Hnrnpab heterogeneous nuclear ribonucleoprotein A/B severity ISO mRNA:increased expression:liver (human) RGD PMID:24638979 RGD:10059322 NCBI chr10:35,857,040...35,862,935
Ensembl chr10:35,857,041...35,863,344
JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D ISO
IEP
protein:increased expression:liver (human)
protein:increased expression:liver (rat)
RGD PMID:20102719 PMID:22318685 RGD:10042969, RGD:10042977 NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786
JBrowse link
G Hnrnph1 heterogeneous nuclear ribonucleoprotein H1 ISO protein:increased expression:liver (human) RGD PMID:23633480 RGD:9685423 NCBI chr10:34,692,868...34,702,849
Ensembl chr10:34,693,555...34,702,846
JBrowse link
G Hnrnpl heterogeneous nuclear ribonucleoprotein L ISO associated with Hepatitis B RGD PMID:24125732 RGD:9999429 NCBI chr 1:84,098,558...84,111,568
Ensembl chr 1:84,100,879...84,111,553
JBrowse link
G Hoxa10 homeobox A10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:81,331,591...81,340,878
Ensembl chr 4:81,331,591...81,340,919
JBrowse link
G Hoxa13 homeo box A13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:81,358,956...81,361,091
Ensembl chr 4:81,358,956...81,361,091
JBrowse link
G Hoxd9 homeo box D9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:59,600,575...59,602,755
Ensembl chr 3:59,600,575...59,602,754
JBrowse link
G Hp haptoglobin ISO protein:increased expression:saliva
protein:decreased expression:liver (human)
RGD PMID:31041878 PMID:24259486 RGD:27095881, RGD:152995276 NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 IEP protein:increased activity:hepatoma (rat) RGD PMID:6327016 RGD:5135035 NCBI chr  X:132,736,175...132,768,149
Ensembl chr  X:132,736,096...132,768,154
JBrowse link
G Hras HRas proto-oncogene, GTPase treatment ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)
human cells in a mouse model
human plasmid in a mouse model
mRNA:increased expression:liver (mouse)
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD
ClinVar
RGD
PMID:8200073 PMID:9311599 PMID:11150980 PMID:12835555 PMID:16155195 More... RGD:14688054, RGD:14688055, RGD:14694809, RGD:14694810 NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
JBrowse link
G Hsd3b2 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 PMID:29698666 NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
JBrowse link
G Hspa9 heat shock protein family A (Hsp70) member 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr18:26,536,131...26,554,294
Ensembl chr18:26,535,798...26,554,292
JBrowse link
G Hspb1 heat shock protein family B (small) member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 ISO CTD Direct Evidence: therapeutic CTD PMID:16799960 NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629
JBrowse link
G Htra1 HtrA serine peptidase 1 exacerbates
disease_progression
ISO protein:decreased expression:liver (human)
mRNA:decreased expression:liver (human)
RGD PMID:20943460 PMID:26403966 RGD:152985524, RGD:152985529 NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
JBrowse link
G Icam1 intercellular adhesion molecule 1 severity ISO protein:increased expression:serum RGD PMID:26109813 RGD:11056752 NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
JBrowse link
G Idh1 isocitrate dehydrogenase (NADP(+)) 1 ISO CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hepatocellular cancer
CTD
ClinVar
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 More... NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
JBrowse link
G Idh2 isocitrate dehydrogenase (NADP(+)) 2 disease_progression ISO ClinVar Annotator: match by term: Hepatocellular cancer ClinVar
RGD
PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 More... RGD:14985249 NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
JBrowse link
G Ier2 immediate early response 2 ISO mRNA, protein:decreased expression:liver (human) RGD PMID:32009420 RGD:153323326 NCBI chr19:23,494,551...23,496,075
Ensembl chr19:23,494,184...23,499,211
JBrowse link
G Ifna1 interferon, alpha 1 susceptibility ISO CTD Direct Evidence: therapeutic
associated with hepatitis B; DNA:SNP:: ( rs1831583) (human)
CTD
RGD
PMID:17088986 PMID:17971768 PMID:18665156 PMID:29080269 RGD:21406429 NCBI chr 5:103,097,356...103,097,925
Ensembl chr 5:103,097,356...103,097,925
JBrowse link
G Ifng interferon gamma ISO mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
JBrowse link
G Ifnl1 interferon, lambda 1 ameliorates ISO human protein and cells in mouse model RGD PMID:24769671 RGD:126848750 NCBI chr 1:83,798,651...83,800,297
Ensembl chr 1:83,798,703...83,800,235
JBrowse link
G Igbp1 immunoglobulin binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21339737 NCBI chr  X:65,582,832...65,605,078
Ensembl chr  X:65,582,821...65,606,049
JBrowse link
G Igf1 insulin-like growth factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
JBrowse link
G Igf1r insulin-like growth factor 1 receptor susceptibility ISO CTD Direct Evidence: marker/mechanism
DNA:SNPs, haplotype: :
CTD
RGD
PMID:17441810 PMID:23958494 PMID:24758241 RGD:14985227 NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
JBrowse link
G Igf2 insulin-like growth factor 2 susceptibility IEP
ISO
CTD Direct Evidence: marker/mechanism
associated with hepatitis B;DNA:SNPs:intron, 3'utr:+2482A>C, +820A>G (human)
CTD
RGD
PMID:12532445 PMID:16092956 PMID:17554210 PMID:16750516 RGD:2311523, RGD:14401723 NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
JBrowse link
G Igf2bp1 insulin-like growth factor 2 mRNA binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129
JBrowse link
G Igf2bp3 insulin-like growth factor 2 mRNA binding protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865
JBrowse link
G Igf2r insulin-like growth factor 2 receptor disease_progression
no_association
treatment
ISO DNA:mutation:G1449V (human)
CTD Direct Evidence: marker/mechanism
protein:increased expression:serum:
DNA:loss of heterozygosity:liver
DNA:loss of heterozygosity,mutations:liver:
associated with hepatitis B virus; mRNA:decreased expression:liver:
ClinVar Annotator: match by term: Hepatocellular carcinoma
OMIM
CTD
ClinVar
RGD
PMID:9722161 PMID:15057872 PMID:25741868 PMID:7493029 PMID:29940770 More... RGD:1624323, RGD:14985218, RGD:14985219, RGD:14985220, RGD:14985221, RGD:14985222, RGD:14985225 NCBI chr 1:47,979,109...48,067,501
Ensembl chr 1:47,979,109...48,067,501
JBrowse link
G Igfals insulin-like growth factor binding protein, acid labile subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:13,897,468...13,903,920
Ensembl chr10:13,898,395...13,902,677
JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
JBrowse link
G Ikbkg inhibitor of nuclear factor kappa B kinase regulatory subunit gamma treatment ISO protein:decreased expression:liver (human) RGD PMID:29551768 PMID:22176836 PMID:25173965 PMID:17292824 PMID:24971483 More... RGD:153297807, RGD:153297813, RGD:153305943, RGD:153305945, RGD:11079569, RGD:153305947 NCBI chr  X:152,216,485...152,241,476
Ensembl chr  X:152,216,596...152,239,499
JBrowse link
G Ikzf1 IKAROS family zinc finger 1 ameliorates ISO protein:increased expression:liver (human) RGD PMID:25301737 RGD:150540326 NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
JBrowse link
G Il10 interleukin 10 treatment IDA
ISO
RGD PMID:23822114 PMID:26890368 RGD:7365006, RGD:14975171 NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
JBrowse link
G Il12a interleukin 12A susceptibility ISO associated with hepatitis C;DNA:SNP:3'UTR: rs568408( G>A)(human)
associated with hepatitis B; DNA:SNP, haplotype:3′UTR :rs568408(human)
RGD PMID:27819525 PMID:20521253 PMID:26631030 RGD:25440490, RGD:25440491, RGD:25440501 NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
JBrowse link
G Il15ra interleukin 15 receptor subunit alpha disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr17:66,802,300...66,831,973
Ensembl chr17:66,802,334...66,832,278
JBrowse link
G Il18 interleukin 18 severity
disease_progression
susceptibility
ISO associated with hepatitis C;DNA:SNPs, haplotype:promoter:-607C>A, -137G>C(human)
DNA:SNP:promoter:-137G>C(rs187238)(human)
associated with hepatitis B, chronic;DNA:SNP:promoter:-607C>A(human)
RGD PMID:29341496 PMID:26893476 PMID:27429592 PMID:27470888 RGD:14695526, RGD:11538094, RGD:14695540, RGD:14696663 NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
JBrowse link
G Il18r1 interleukin 18 receptor 1 ISO mRNA:decreased expression:liver RGD PMID:26893476 PMID:26893476 RGD:11538094, RGD:11538094 NCBI chr 9:42,727,416...42,760,971
Ensembl chr 9:42,727,869...42,760,715
JBrowse link
G Il1b interleukin 1 beta susceptibility ISO DNA:polymorphism:promoter:-31T>C (human) RGD PMID:21653279 RGD:7401222 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G Il1rap interleukin 1 receptor accessory protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:74,062,999...74,199,530
Ensembl chr11:74,070,304...74,199,530
JBrowse link
G Il1rn interleukin 1 receptor antagonist ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:7,111,567...7,127,451
Ensembl chr 3:7,111,550...7,127,445
JBrowse link
G Il2 interleukin 2 treatment ISO RGD PMID:10933975 PMID:9449371 RGD:8693323, RGD:14747035 NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
JBrowse link
G Il21 interleukin 21 ISO associated with hepatitis B;DNA:SNPS, haplotype:(rs13143866, rs2221903, rs907715) (human) RGD PMID:25892873 RGD:127285359 NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
JBrowse link
G Il6 interleukin 6 treatment
disease_progression
ISO CTD Direct Evidence: marker/mechanism
DNA:SNP: :rs2069852 (human)
mRNA,protein:increased expression:liver, blood serum (mouse)
CTD
RGD
PMID:17615358 PMID:20818158 PMID:26297436 PMID:27022031 PMID:27368337 More... RGD:14975289, RGD:11344640 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Il6st interleukin 6 cytokine family signal transducer IEP RGD PMID:15780071 RGD:1626706 NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
JBrowse link
G Ing3 inhibitor of growth family, member 3 treatment IDA RGD PMID:25156538 RGD:9587823 NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:50,477,962...50,503,715
JBrowse link
G Inmt indolethylamine N-methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
JBrowse link
G Inpp4b inositol polyphosphate-4-phosphatase type II B ISO CTD Direct Evidence: marker/mechanism CTD PMID:29415082 NCBI chr19:25,920,189...26,670,085
Ensembl chr19:25,925,358...26,280,634
JBrowse link
G Ins1 insulin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
JBrowse link
G Ins2 insulin 2 ISO associated with Chronic Hepatitis C;mRNA:decreased expression:liver (human) RGD PMID:33132693 RGD:150340613 NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
JBrowse link
G Insr insulin receptor IEP
IMP
mRNA, protein:increased expression:liver (human, rat)
human cells in a mouse model
RGD PMID:23633480 PMID:29610518 RGD:9685423, RGD:14700930 NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
JBrowse link
G Iqgap1 IQ motif containing GTPase activating protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20977743 NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
JBrowse link
G Iqgap2 IQ motif containing GTPase activating protein 2 ISO
ISS
CTD Direct Evidence: marker/mechanism
OMIM:114550
CTD
MouseDO
PMID:20977743 NCBI chr 2:26,894,836...27,170,270
Ensembl chr 2:26,894,825...27,170,279
JBrowse link
G Iqgap3 IQ motif containing GTPase activating protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:173,542,151...173,583,956
Ensembl chr 2:173,542,110...173,583,956
JBrowse link
G Irf2 interferon regulatory factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22561517 NCBI chr16:45,439,215...45,550,054
Ensembl chr16:45,439,225...45,550,024
JBrowse link
G Irs1 insulin receptor substrate 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:1311924 PMID:23958494 NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
JBrowse link
G Irs2 insulin receptor substrate 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16127164 NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482
JBrowse link
G Isg15 ISG15 ubiquitin-like modifier ISO CTD Direct Evidence: marker/mechanism CTD PMID:28919514 NCBI chr 5:166,784,148...166,785,435
Ensembl chr 5:166,784,148...166,785,435
JBrowse link
G Itih3 inter-alpha trypsin inhibitor, heavy chain 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr16:6,101,922...6,117,154
Ensembl chr16:6,101,930...6,116,924
JBrowse link
G Itih4 inter-alpha-trypsin inhibitor heavy chain 4 disease_progression ISO associated with hepatitis B;protein:decreased expression:serum RGD PMID:24836184 RGD:40903002 NCBI chr16:6,080,539...6,095,710
Ensembl chr16:6,080,539...6,095,708
JBrowse link
G Jag1 jagged canonical Notch ligand 1 ISO protein:increased expression:liver RGD PMID:30660174 RGD:14694832 NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
JBrowse link
G Jak1 Janus kinase 1 ISO RGD PMID:23788652 RGD:150524353 NCBI chr 5:115,780,248...115,888,841
Ensembl chr 5:115,780,248...115,888,926
JBrowse link
G Jak2 Janus kinase 2 severity
exacerbates
ameliorates
treatment
IEP
ISO
mRNA:decreased expression:liver (human)
protein:increased phosphorylation:liver (human)
protein:increased phosphorylation:liver (mouse)
associated with Diseases of the Aged and non-alcoholic fatty liver disease
L-JAK2 KO
RGD PMID:25420511 PMID:22392353 PMID:22821478 PMID:31393852 PMID:28100771 More... RGD:18182928, RGD:125097525, RGD:127285621, RGD:127285655, RGD:127285675, RGD:127285672 NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
JBrowse link
G Jdp2 Jun dimerization protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20214788 NCBI chr 6:105,261,619...105,302,386
Ensembl chr 6:105,261,373...105,301,485
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:20214788 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
JBrowse link
G Jund JunD proto-oncogene, AP-1 transcription factor subunit ISO associated with HBV;protein:increased expression:liver (human) RGD PMID:15927205 RGD:153297768 NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
JBrowse link
G Kat2b lysine acetyltransferase 2B severity ISO protein:decreased expression:liver (human) RGD PMID:23643089 RGD:9590314 NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
JBrowse link
G Kbtbd11 kelch repeat and BTB domain containing 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
JBrowse link
G Kcnh1 potassium voltage-gated channel subfamily H member 1 ISO protein:increased expression:liver (human) RGD PMID:17022810 RGD:9693723 NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740
JBrowse link
G Kcnn2 potassium calcium-activated channel subfamily N member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:37,817,966...38,258,347
Ensembl chr18:37,817,957...38,258,347
JBrowse link
G Kdm1a lysine demethylase 1A severity ISO mRNA, protein:increased expression:liver (human) RGD PMID:23236241 RGD:9681002 NCBI chr 5:148,782,976...148,838,319
Ensembl chr 5:148,782,976...148,838,319
JBrowse link
G Kdm3a lysine demethylase 3A ISO mRNA:increased expression:liver (human) RGD PMID:21607773 RGD:9590222 NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
JBrowse link
G Kdm5c lysine demethylase 5C exacerbates ISO protein:increased expression:liver (human) RGD PMID:26503415 RGD:11530160 NCBI chr  X:21,345,459...21,387,045
Ensembl chr  X:21,345,481...21,381,870
JBrowse link
G Kdm6a lysine demethylase 6A ameliorates ISO human cells in a mouse model RGD PMID:32765772 RGD:150429729 NCBI chr  X:4,337,466...4,477,100
Ensembl chr  X:4,337,750...4,477,062
JBrowse link
G Kdm8 lysine demethylase 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:180,013,969...180,028,829
Ensembl chr 1:180,020,656...180,028,841
JBrowse link
G Kdr kinase insert domain receptor treatment
disease_progression
ISO DNA:SNPs: :rs1870377, rs2071559, rs2305948 (human)
protein:increased expression:liver
protein:decreased expression:liver
associated with alcoholic liver cirrhosis;DNA:SNP: :1416A>T (human)
RGD PMID:25182707 PMID:19177438 PMID:25333267 PMID:23660204 PMID:24445728 RGD:126848806, RGD:126848810, RGD:126848812, RGD:126848813, RGD:126848814 NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
JBrowse link
G Keap1 Kelch-like ECH-associated protein 1 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
JBrowse link
G Kif11 kinesin family member 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:235,124,371...235,176,760
Ensembl chr 1:235,124,316...235,176,766
JBrowse link
G Kif14 kinesin family member 14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:47,926,975...47,990,598
Ensembl chr13:47,927,044...47,989,164
JBrowse link
G Kif15 kinesin family member 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:122,601,888...122,672,750
Ensembl chr 8:122,601,897...122,672,750
JBrowse link
G Kif18a kinesin family member 18A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582
JBrowse link
G Kif18b kinesin family member 18B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:87,870,424...87,889,895
Ensembl chr10:87,870,428...87,889,850
JBrowse link
G Kif1b kinesin family member 1B severity
susceptibility
ISO mRNA, protein:decreased expression:liver (human)
DNA:snp:intron:c.2537+518A>G (rs17401966) (human)
RGD PMID:26217094 PMID:27122668 RGD:11052488, RGD:12738461 NCBI chr 5:159,607,697...159,742,778
Ensembl chr 5:159,561,271...159,742,778
JBrowse link
G Kif20a kinesin family member 20A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:26,230,294...26,238,780
Ensembl chr18:26,230,230...26,238,780
JBrowse link
G Kif23 kinesin family member 23 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:62,397,908...62,425,162
Ensembl chr 8:62,397,948...62,425,072
JBrowse link
G Kif2c kinesin family member 2C ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637
JBrowse link
G Kif4a kinesin family member 4A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:65,721,746...65,824,277
Ensembl chr  X:65,721,779...65,824,139
JBrowse link
G Kifc1 kinesin family member C1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr20:4,998,832...5,017,107
Ensembl chr20:4,999,047...5,017,105
JBrowse link
G Klf4 KLF transcription factor 4 disease_progression
treatment
ISO RGD PMID:22677193 PMID:22677193 RGD:14402023, RGD:14402023 NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
JBrowse link
G Klrb1 killer cell lectin like receptor B1 disease_progression ISO mRNA:decreased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 4:162,456,294...162,474,989
Ensembl chr 4:162,456,294...162,474,989
JBrowse link
G Kmt2a lysine methyltransferase 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:22634756 NCBI chr 8:45,116,763...45,193,320
Ensembl chr 8:45,118,814...45,193,181
JBrowse link
G Kmt2b lysine methyltransferase 2B ISO DNA:insertions, translocations:intron:IVS3, multiple (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:22634754 PMID:18320596 RGD:9588597 NCBI chr 1:85,821,700...85,840,987
Ensembl chr 1:85,821,753...85,841,326
JBrowse link
G Kmt2c lysine methyltransferase 2C ISO CTD Direct Evidence: marker/mechanism CTD PMID:22634756 NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
JBrowse link
G Kras KRAS proto-oncogene, GTPase induced ISO
IAGP
CTD Direct Evidence: marker/mechanism
aflatoxin B1 induced:DNA:transversion,transition mutations:cds:
mRNA,protein:increased expression:liver
ClinVar Annotator: match by term: Hepatocellular cancer
CTD
ClinVar
RGD
PMID:2278970 PMID:3122217 PMID:11286481 PMID:11563603 PMID:12460918 More... RGD:11568697, RGD:14398750 NCBI chr 4:178,185,418...178,218,484 JBrowse link
G Krt18 keratin 18 ISS OMIM:114550 MouseDO NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
JBrowse link
G Lcat lecithin cholesterol acyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
JBrowse link
G Lect2 leukocyte cell-derived chemotaxin 2 ameliorates ISO protein:increased expression:blood serum (mouse)
protein:increased expression:blood serum (human)
human cells in mouse model
RGD PMID:24892551 PMID:24892551 PMID:21394108 RGD:153323333, RGD:153323333, RGD:153323335 NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983
JBrowse link
G Lep leptin susceptibility
severity
IAGP
IEP
DNA:SNP:enhancer:-2548G>A (rs7799039) (human)
protein:increased expression:liver (human)
RGD PMID:28452232 PMID:18573568 RGD:15039399, RGD:25330348 NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
JBrowse link
G Lepr leptin receptor susceptibility ISO associated with Hepatitis B, Chronic;DNA:SNPs:cds:p.Gln223Arg, Lys109Arg (human) RGD PMID:23090836 RGD:21079466 NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
JBrowse link
G Letm1 leucine zipper and EF-hand containing transmembrane protein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:23392203 NCBI chr14:76,942,647...76,982,220
Ensembl chr14:76,942,729...76,984,904
JBrowse link
G Lifr LIF receptor subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:56,224,393...56,292,988
Ensembl chr 2:56,250,120...56,286,699
JBrowse link
G Lilrb3 leukocyte immunoglobulin like receptor B3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:69,928,948...69,939,461
Ensembl chr 1:69,928,945...69,939,048
JBrowse link
G Loxl3 lysyl oxidase-like 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35841383 NCBI chr 4:115,540,640...115,556,958
Ensembl chr 4:115,540,685...115,557,466
JBrowse link
G Lpar1 lysophosphatidic acid receptor 1 IDA RGD PMID:19000703 RGD:2317680 NCBI chr 5:73,229,047...73,347,874
Ensembl chr 5:73,229,625...73,369,895
JBrowse link
G Lrat lecithin retinol acyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:168,264,093...168,273,155
Ensembl chr 2:168,266,877...168,273,619
JBrowse link
G Lrp1b LDL receptor related protein 1B exacerbates ISO protein:increased expression:liver (human)
DNA:mutations:multiple: (human)
RGD PMID:33324588 PMID:33391418 RGD:150429776, RGD:150429785 NCBI chr 3:24,594,302...26,715,037
Ensembl chr 3:24,594,991...26,715,505
JBrowse link
G Lrrc1 leucine rich repeat containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:78,239,897...78,407,347
Ensembl chr 8:78,239,900...78,406,490
JBrowse link
G Lrrc56 leucine rich repeat containing 56 ISO ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 More... NCBI chr 1:196,299,843...196,315,170
Ensembl chr 1:196,299,846...196,315,172
JBrowse link
G Lrrc59 leucine rich repeat containing 59 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr10:79,572,295...79,586,953
Ensembl chr10:79,572,317...79,602,533
JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:164,962,872...164,976,309
Ensembl chr 1:164,962,872...164,976,309
JBrowse link
G Lztr1 leucine zipper like post translational regulator 1 ISO DNA:missense mutation:cds, liver (human) RGD PMID:28622513 RGD:151893487 NCBI chr11:83,487,717...83,503,896
Ensembl chr11:83,487,717...83,503,633
JBrowse link
G Mad2l1 mitotic arrest deficient 2 like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
JBrowse link
G Magec2 MAGE family member C2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:140,610,610...140,615,484
Ensembl chr  X:140,606,825...140,615,471
JBrowse link
G Map2k2 mitogen activated protein kinase kinase 2 exacerbates ISO
IEP
mRNA:increased expression:liver (human)
protein:increased expression:liver, cytosol (rat)
RGD PMID:33553243 PMID:9397988 RGD:150530475, RGD:150530477 NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
JBrowse link
G Map2k3 mitogen activated protein kinase kinase 3 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr10:45,608,145...45,629,492
Ensembl chr10:45,607,163...45,629,492
JBrowse link
G Map2k4 mitogen activated protein kinase kinase 4 ISO protein:decreased expression:liver (human) RGD PMID:32850377 RGD:150429765 NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993
JBrowse link
G Map3k1 mitogen-activated protein kinase kinase kinase 1 exacerbates ISO mRNA:decreased expression:liver (human) RGD PMID:31310010 RGD:150573714 NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
JBrowse link
G Map3k8 mitogen-activated protein kinase kinase kinase 8 ameliorates ISO RGD PMID:26560698 RGD:11342977 NCBI chr17:53,382,908...53,403,216
Ensembl chr17:53,383,131...53,403,216
JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 ameliorates
severity
treatment
ISO human cell line in a mouse model
human recombinant gene and cell line in a mouse model
RGD PMID:21196414 PMID:27010469 PMID:31922225 RGD:151347673, RGD:151347674, RGD:151347839 NCBI chr 9:42,200,708...42,326,708
Ensembl chr 9:42,200,278...42,326,698
JBrowse link
G Mapk1 mitogen activated protein kinase 1 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:26619011 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
JBrowse link
G Mapk14 mitogen activated protein kinase 14 treatment
exacerbates
ISO RGD PMID:25216638 PMID:23271722 RGD:151665347, RGD:151665348 NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 ameliorates ISO protein:decreased phosphorylation:liver (human) RGD PMID:33875785 RGD:150340688 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
JBrowse link
G Mapt microtubule-associated protein tau ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
JBrowse link
G Marco macrophage receptor with collagenous structure ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:31,616,278...31,648,521
Ensembl chr13:31,616,278...31,648,521
JBrowse link
G Mat1a methionine adenosyltransferase 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:12060674 NCBI chr16:16,983,084...17,001,284
Ensembl chr16:16,983,022...17,001,274
JBrowse link
G Mbl2 mannose binding lectin 2 severity
susceptibility
no_association
ISO associated with hepatitis C;DNA:SNP: :221C>G(rs709620)(human)
associated with hepatitis B-related cirrhosis;DNA:SNP: :rs11003123(G>A)(human)
associated with viral hepatitis;DNA:polymorphisms:exon:
DNA:SNPs:promoter:rs7096206(human)
protein:decreased expression:plasma
associated with hepatitis B;DNA:SNP:exon:
RGD PMID:21733090 PMID:27298104 PMID:18221301 PMID:25787238 PMID:27557564 More... RGD:14696813, RGD:14696814, RGD:14696829, RGD:14696833, RGD:14696835, RGD:14696836 NCBI chr 1:228,016,439...228,024,736 JBrowse link
G Mbtps1 membrane-bound transcription factor peptidase, site 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14563831 NCBI chr19:47,561,598...47,612,769
Ensembl chr19:47,561,598...47,612,791
JBrowse link
G Mbtps2 membrane-bound transcription factor peptidase, site 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14563831 NCBI chr  X:37,410,914...37,461,130
Ensembl chr  X:37,410,811...37,464,430
JBrowse link
G Mcm10 minichromosome maintenance 10 replication initiation factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:73,263,788...73,288,346
Ensembl chr17:73,266,095...73,287,364
JBrowse link
G Mcm2 minichromosome maintenance complex component 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847
JBrowse link
G Mcm7 minichromosome maintenance complex component 7 susceptibility IAGP
IEP
associated with hepatitis B;DNA:SNP:promoter: (rs999885) (human)
associated with hepatitis B;miRNA:increased expression:liver (human)
RGD PMID:24416400 PMID:27298561 RGD:15042885, RGD:15042853 NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
JBrowse link
G Mcm9 minichromosome maintenance 9 homologous recombination repair factor ISS OMIM:114550 MouseDO NCBI chr20:32,818,219...32,929,577
Ensembl chr20:32,844,951...32,929,600
JBrowse link
G Mdm2 MDM2 proto-oncogene susceptibility ISO DNA:transversion:promoter:g.-309T>G (human) RGD PMID:20019189 RGD:2317357 NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
JBrowse link
G Me1 malic enzyme 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
JBrowse link
G Mecp2 methyl CpG binding protein 2 ISO
IEP
CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:liver
CTD
RGD
PMID:26189965 PMID:11844796 RGD:2289670 NCBI chr  X:151,781,177...151,844,687
Ensembl chr  X:151,789,930...151,844,689
JBrowse link
G Med1 mediator complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20007298 NCBI chr10:83,145,538...83,189,260
Ensembl chr10:83,145,568...83,189,299
JBrowse link
G Melk maternal embryonic leucine zipper kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:58,540,393...58,600,562
Ensembl chr 5:58,540,449...58,600,937
JBrowse link
G Met MET proto-oncogene, receptor tyrosine kinase severity IEP
ISO
protein:increased expression:liver (rat)
mRNA:increased expression:liver, carcinoma (human)
CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)
ClinVar Annotator: match by term: Hepatocellular cancer
CTD
ClinVar
OMIM
RGD
PMID:21774103 PMID:21970370 PMID:22703879 PMID:24728327 PMID:25741868 More... RGD:2317495, RGD:2317575, RGD:1600123, RGD:152995524, RGD:152995524 NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
JBrowse link
G Mill1 MHC I like leukocyte 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21499248 NCBI chr 1:78,372,798...78,398,932
Ensembl chr 1:78,372,802...78,398,930
JBrowse link
G Mir106b microRNA 106b disease_progression
severity
IEP miRNA:decreased expression:liver (human)
miRNA:increased expression:plasma (human)
miRNA:increased expression:serum (human)
miRNA:increased expression:liver (human)
RGD PMID:28958640 PMID:25894380 PMID:28611524 PMID:31406464 RGD:15042874, RGD:15042875, RGD:15042876, RGD:15042877 NCBI chr12:17,043,344...17,043,425
Ensembl chr12:17,043,344...17,043,425
JBrowse link
G Mir107 microRNA 107 treatment
onset
ISO RNA:decreased expression:liver:
RNA:increased expression:liver:
RGD PMID:30738047 PMID:27773820 PMID:26191213 PMID:28079796 RGD:14975277, RGD:14975278, RGD:11066920, RGD:14975300 NCBI chr 1:232,337,767...232,337,853
Ensembl chr 1:232,337,767...232,337,853
JBrowse link
G Mir122 microRNA 122 severity ISO CTD Direct Evidence: marker/mechanism
associated with hepatitis B miRNA:decreased expression:liver
protein:decreased expression:liver (human)
mRNA:decreased expression:blood (human)
CTD
RGD
PMID:16924677 PMID:25269820 PMID:25422324 PMID:19584283 PMID:27528885 RGD:14394424, RGD:14401603, RGD:151356981, RGD:151361113 NCBI chr18:58,758,703...58,758,787 JBrowse link
G Mir125a microRNA 125a treatment
severity
ISO RNA:increased expression:liver: RGD PMID:30257386 PMID:30257386 PMID:29951066 RGD:21403677, RGD:21403677, RGD:21403679 NCBI chr 1:58,677,626...58,677,710
Ensembl chr 1:58,677,626...58,677,710
JBrowse link
G Mir127 microRNA 127 ISO miRNA:decreased expression:liver (human) RGD PMID:24854842 RGD:152995355 NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:128,546,215...128,546,311
JBrowse link
G Mir130b microRNA 130b severity ISO miRNA:increased expression:liver RGD PMID:25387077 RGD:14694845 NCBI chr11:83,880,163...83,880,244
Ensembl chr11:83,880,163...83,880,244
JBrowse link
G Mir133a1 microRNA 133a-1 disease_progression ISO mRNA:decreased expression:liver (human)
human cells in mouse model
RGD PMID:30086463 PMID:30086463 RGD:153344517, RGD:153344517 NCBI chr18:1,885,082...1,885,168 JBrowse link
G Mir133b microRNA 133b severity ISO mRNA:decreased expression:liver(human) RGD PMID:30391496 RGD:155804298 NCBI chr 9:23,098,134...23,098,217
Ensembl chr 9:23,098,134...23,098,217
JBrowse link
G Mir136 microRNA 136 exacerbates ISO RNA:decreased expression:liver (human) RGD PMID:28849100 RGD:153345547 NCBI chr 6:128,549,096...128,549,177
Ensembl chr 6:128,549,096...128,549,177
JBrowse link
G Mir139 microRNA 139 ISO RNA:decreased expression:liver (human) RGD PMID:30710422 RGD:153344549 NCBI chr 1:155,878,828...155,878,895
Ensembl chr 1:155,878,825...155,878,902
JBrowse link
G Mir145 microRNA 145 severity IEP miRNA:decreased expression:liver (human) RGD PMID:30572504 RGD:15039395 NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
JBrowse link
G Mir146a microRNA 146a sexual_dimorphism
susceptibility
ISO associated with hepatitis B;miRNA:SNP:exon: (rs2910164) (human)
miRNA:SNP: (human)
associated with hepatitis B;miRNA:SNP: (human)
RGD PMID:18711148 PMID:24816919 PMID:24615520 RGD:126925148, RGD:126925158, RGD:126925187 NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
JBrowse link
G Mir150 microRNA 150 ISO mRNA:decreased expression:liver (human) RGD PMID:30205391 RGD:153344577 NCBI chr 1:95,605,024...95,605,108
Ensembl chr 1:95,605,024...95,605,108
JBrowse link
G Mir152 microRNA 152 disease_progression ISO miRNA:decreased expression:liver RGD PMID:30967300 PMID:26531720 RGD:19165146, RGD:21066331 NCBI chr10:81,832,936...81,833,020
Ensembl chr10:81,832,936...81,833,020
JBrowse link
G Mir154 microRNA 154 ISO RNA:decreased expression:liver (human) RGD PMID:33195697 RGD:152995478 NCBI chr 6:128,752,947...128,753,030
Ensembl chr 6:128,752,947...128,753,030
JBrowse link
G Mir155 microRNA 155 disease_progression ISO miRNA:decreased expression:peripheral blood mononuclear cell
miRNA:increased expression:serum
associated with hepatitis C;DNA:SNP: :rs767649 (human)
RGD PMID:27035278 PMID:27035278 PMID:28074870 PMID:30710754 PMID:29528577 More... RGD:21079433, RGD:21079433, RGD:21079477, RGD:21081523, RGD:24922222, RGD:25671465 NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718
JBrowse link
G Mir181c microRNA 181c IEP miRNA:decreased expression:liver (human) RGD PMID:31114379 RGD:15042894 NCBI chr19:23,983,523...23,983,628
Ensembl chr19:23,983,523...23,983,628
JBrowse link
G Mir18a microRNA 18a severity IEP miRNA:increased expression:liver (human)
associated with hepatitis B;miRNA:increased expression:liver (human)
associated with Hepatitis C, Chronic;miRNA:increased expression:serum (human)
RGD PMID:19027010 PMID:30519035 PMID:30191950 PMID:24975878 PMID:29455432 RGD:15039398, RGD:15039400, RGD:15039389, RGD:15039401, RGD:15039404 NCBI chr15:92,180,765...92,180,860
Ensembl chr15:92,180,765...92,180,860
JBrowse link
G Mir193a microRNA 193a disease_progression
exacerbates
ISO miRNA:decreased expression:liver (human)
RNA:increased expression:blood serum (human)
DNA:hypomethylation
RGD PMID:26263159 PMID:30710422 PMID:32960907 PMID:28036298 RGD:11070076, RGD:153344549, RGD:153344563, RGD:153344564 NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
JBrowse link
G Mir195 microRNA 195 severity IEP
IMP
miRNA:decreased expression:liver (human)
miRNA:decreased expression:liver (mouse)
RGD PMID:25607636 PMID:25607636 RGD:15042896, RGD:15042896 NCBI chr10:54,951,838...54,951,924
Ensembl chr10:54,951,838...54,951,924
JBrowse link
G Mir196a microRNA 196a susceptibility ISO DNA:SNP: : (rs11614913)
associated with hepatitis B, chronic; DNA:SNP: : (rs12304647)
RGD PMID:21692953 PMID:24248733 RGD:14401594 RGD:14401595 NCBI chr 7:134,110,400...134,110,509
Ensembl chr 7:134,110,400...134,110,509
JBrowse link
G Mir200b microRNA 200b treatment
disease_progression
ISO mRNA:decreased expression:liver
DNA:hypermethylation:promoter
RGD PMID:26919246 PMID:26919246 PMID:28383782 PMID:28383782 PMID:28383782 RGD:14928318, RGD:14928318, RGD:14928322, RGD:14928322, RGD:14928322 NCBI chr 5:166,649,272...166,649,366
Ensembl chr 5:166,649,272...166,649,366
JBrowse link
G Mir20a microRNA 20a ISO associated with Human Viral Hepatitis RGD PMID:30623908 RGD:25823145 NCBI chr15:92,181,084...92,181,168
Ensembl chr15:92,181,084...92,181,168
JBrowse link
G Mir21 microRNA 21 severity
treatment
ISO miRNA:increased expression:liver RGD PMID:20447717 PMID:24963487 PMID:21749846 RGD:14695022, RGD:40925952, RGD:41404642 NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
JBrowse link
G Mir212 microRNA 212 disease_progression
ameliorates
ISO RGD PMID:25965836 PMID:25965836 RGD:11054501, RGD:11054501 NCBI chr10:60,023,403...60,023,513
Ensembl chr10:60,023,403...60,023,513
JBrowse link
G Mir22 microRNA 22 severity
disease_progression
ISO in male; RNA:increased expression:liver: RGD PMID:23766411 PMID:27811373 PMID:21750200 RGD:14700874, RGD:14700875, RGD:14700876 NCBI chr10:60,307,039...60,307,133
Ensembl chr10:60,307,039...60,307,133
JBrowse link
G Mir221 microRNA 221 disease_progression
treatment
ISO
IEP
RGD PMID:25817558 PMID:29713162 PMID:29713162 PMID:22009537 PMID:28096271 More... RGD:11086123, RGD:18337267, RGD:18337267, RGD:18337273, RGD:18337275, RGD:18337275, RGD:18337275, RGD:151893509 NCBI chr  X:3,429,465...3,429,573
Ensembl chr  X:3,429,465...3,429,573
JBrowse link
G Mir222 microRNA 222 disease_progression
severity
ISO RGD PMID:24124720 PMID:20103675 RGD:151709003, RGD:151709004 NCBI chr  X:3,428,904...3,429,006
Ensembl chr  X:3,428,904...3,429,006
JBrowse link
G Mir223 microRNA 223 disease_progression ISO associated with high-fat diet,
associated with Chronic HepatitisC; RNA:decreased expression:serum:
associated with Chronic Hepatitis B; RNA:decreased expression:serum:
RNA:increased expression:serum:
RGD PMID:30964207 PMID:28982915 PMID:25391771 PMID:24595450 PMID:21229610 RGD:21408549, RGD:21408578, RGD:21408580, RGD:21408583, RGD:21408591 NCBI chr  X:61,141,887...61,141,996
Ensembl chr  X:61,141,887...61,141,996
JBrowse link
G Mir224 microRNA 224 severity IEP miRNA:increased expression:liver (human)
associated with hepatitis B;miRNA:increased expression:liver (human)
miRNA:increased expression:plasma (human)
RGD PMID:23922662 PMID:22459148 PMID:23913306 PMID:24923856 PMID:27462777 RGD:18182921, RGD:18182922, RGD:18182923, RGD:18182924, RGD:18182926 NCBI chr  X:150,065,088...150,065,169
Ensembl chr  X:150,065,088...150,065,169
JBrowse link
G Mir23a microRNA 23a ISO miRNA:increased expression:liver RGD PMID:22318941 RGD:14694846 NCBI chr19:23,954,997...23,955,071
Ensembl chr19:23,954,997...23,955,071
JBrowse link
G Mir23b microRNA 23b ISO DNA:hypermethylation RGD PMID:28036298 RGD:153344564 NCBI chr17:1,813,667...1,813,763
Ensembl chr17:1,813,667...1,813,763
JBrowse link
G Mir25 microRNA 25 severity IEP miRNA:increased expression:liver (human)
associated with hepatitis B;miRNA:increased expression:serum (human)
associated with hepatitis B;miRNA:increased expression:liver (human)
RGD PMID:30191950 PMID:24593846 PMID:21098710 PMID:27298561 RGD:15039389, RGD:15042897, RGD:15042899, RGD:15042853 NCBI chr12:17,042,932...17,043,015
Ensembl chr12:17,042,932...17,043,015
JBrowse link
G Mir27a microRNA 27a severity
treatment
ISO human cell line in a mouse model
human miRNA and cell line in a mouse model
RGD PMID:29143999 PMID:30083261 RGD:14696659, RGD:14696660 NCBI chr19:23,954,831...23,954,917
Ensembl chr19:23,954,831...23,954,917
JBrowse link
G Mir29a microRNA 29a severity ISO associated with hepatitis B;miRNA:increased expression:liver (human) RGD PMID:23285022 RGD:15042850 NCBI chr 4:59,650,608...59,650,695 JBrowse link
G Mir31 microRNA 31 severity ISO
IEP
RNA:decreased expression:liver (human)
miRNA:decreased expression:liver (human)
miRNA:decreased expression:liver (rat)
RGD PMID:28623129 PMID:25797269 PMID:25797269 RGD:152998991, RGD:11085965, RGD:11085965 NCBI chr 5:103,599,038...103,599,143 JBrowse link
G Mir340-1 microRNA 340-1 ISO miRNA:decreased expression:liver RGD PMID:27998770 RGD:18936991 NCBI chr10:34,393,568...34,393,665
Ensembl chr10:34,393,568...34,393,665
JBrowse link
G Mir34a microRNA 34a treatment ISO human cell line in a mouse model
miRNA:decreased expression:liver
RGD PMID:25217526 PMID:29328457 RGD:14694835, RGD:14694836 NCBI chr 5:160,533,002...160,533,103
Ensembl chr 5:160,533,002...160,533,103
JBrowse link
G Mir411 microRNA 411 disease_progression ISO mRNA:decreased expression:liver (human) RGD PMID:30086881 RGD:152999437 NCBI chr 6:128,723,189...128,723,264
Ensembl chr 6:128,723,184...128,723,279
JBrowse link
G Mir455 microRNA 455 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35286011 NCBI chr 5:76,689,313...76,689,390
Ensembl chr 5:76,689,313...76,689,390
JBrowse link
G Mir494 microRNA 494 disease_progression ISO RGD PMID:25820676 RGD:155900754 NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
JBrowse link
G Mir615 microRNA 615 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22819824 NCBI chr 7:134,151,887...134,151,978
Ensembl chr 7:134,151,887...134,151,978
JBrowse link
G Mir665 microRNA 665 disease_progression ISO mRNA:increased expression:liver (human)
associated with metastasis; human cells in mouse model
RGD PMID:30237408 PMID:30237408 RGD:151361293, RGD:151361293 NCBI chr 6:128,539,440...128,539,533
Ensembl chr 6:128,539,440...128,539,533
JBrowse link
G Mir93 microRNA 93 severity IEP associated with hepatitis B;miRNA:increased expression:liver (human) RGD PMID:27298561 PMID:28592130 RGD:15042853, RGD:15042900 NCBI chr12:17,043,135...17,043,221
Ensembl chr12:17,043,135...17,043,221
JBrowse link
G Mir96 microRNA 96 severity IEP miRNA:increased expression:liver (human) RGD PMID:28892647 PMID:25813403 RGD:15042901, RGD:15042902 NCBI chr 4:58,788,411...58,788,516
Ensembl chr 4:58,788,411...58,788,516
JBrowse link
G Mirlet7c1 microRNA let-7c-1 ISO miRNA:decreased expression:liver RGD PMID:22289550 RGD:14695021 NCBI chr11:16,201,163...16,201,256
Ensembl chr11:16,201,158...16,201,265
JBrowse link
G Mki67 marker of proliferation Ki-67 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
JBrowse link
G Mlxipl MLX interacting protein-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr12:21,541,608...21,577,120
Ensembl chr12:21,543,576...21,577,112
JBrowse link
G Mme membrane metallo-endopeptidase IEP RGD PMID:8302012 RGD:13801035 NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792
JBrowse link
G Mmp14 matrix metallopeptidase 14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33010264 NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
JBrowse link
G Mmp2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20084675 NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
JBrowse link
G Mmp9 matrix metallopeptidase 9 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:20084675 PMID:21681821 RGD:8547864 NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
JBrowse link
G Mogat2 monoacylglycerol O-acyltransferase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:153,521,813...153,545,756
Ensembl chr 1:153,521,815...153,545,756
JBrowse link
G Mpl MPL proto-oncogene, thrombopoietin receptor ISO human cells in mouse model RGD PMID:23157389 RGD:126925755 NCBI chr 5:131,973,895...131,987,472
Ensembl chr 5:131,973,895...131,986,797
JBrowse link
G Mpo myeloperoxidase susceptibility
disease_progression
ISO CTD Direct Evidence: marker/mechanism
associated with liver cirrhosis; DNA:SNP:promoter:-463G>A( rs2333227)(human)
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-463G>A(human)
CTD
RGD
PMID:19731237 PMID:19731237 PMID:21907168 RGD:26923907, RGD:27095879 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
JBrowse link
G Mro maestro ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:67,450,186...67,467,593
Ensembl chr18:67,450,595...67,467,044
JBrowse link
G Msh3 mutS homolog 3 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:28492532 NCBI chr 2:23,444,326...23,585,777 JBrowse link
G Msh5 mutS homolog 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr20:3,773,867...3,793,337
Ensembl chr20:3,776,942...3,793,336
JBrowse link
G Mt-co1 mitochondrially encoded cytochrome c oxidase I IAGP RGD PMID:2548155 RGD:2302301 NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
JBrowse link
G Mt-nd5 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 IEP mRNA:increased expression:liver RGD PMID:2507335 RGD:2302316 NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
JBrowse link
G Mt1 metallothionein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17363595 PMID:19363144 NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
Ensembl chr17:10,826,032...10,827,049
JBrowse link
G Mt1-ps3 metallothionein 1, pseudogene 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:74,786,652...74,787,040
Ensembl chr17:74,786,654...74,787,135
JBrowse link
G Mt2A metallothionein 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:17363595 PMID:28284560 NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
JBrowse link
G Mtbp MDM2 binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:29765550 NCBI chr 7:86,973,215...87,055,775
Ensembl chr 7:86,973,069...87,050,827
JBrowse link
G Mtdh metadherin treatment ISO human cells in a mouse model RGD PMID:26351209 RGD:11096879 NCBI chr 7:65,306,464...65,365,647
Ensembl chr 7:65,306,400...65,364,413
JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase IEP mRNA:increased expression:liver RGD PMID:3878730 RGD:2302305 NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
JBrowse link
G Mthfr methylenetetrahydrofolate reductase susceptibility
disease_progression
onset
ISO DNA:SNP,haplotype: :677C>T, 1298A>C(human)
DNA:SNP: :677C>T(human)
DNA:SNP: :1298A>C(human)
DNA:SNPs: :677C>T, 1298A>C(human)
RGD PMID:17503006 PMID:23996892 PMID:19035314 PMID:17659576 RGD:14696703, RGD:14696704, RGD:14696707, RGD:14696708 NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
JBrowse link
G Mtor mechanistic target of rapamycin kinase severity ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:liver (human)
CTD
RGD
PMID:21147110 PMID:25371154 RGD:152995471 NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
JBrowse link
G Mtrr 5-methyltetrahydrofolate-homocysteine methyltransferase reductase susceptibility ISO DNA:SNP: :66A>G(human) RGD PMID:19035314 RGD:14696707 NCBI chr 1:34,866,991...34,899,425
Ensembl chr 1:34,867,089...34,899,425
JBrowse link
G Muc4 mucin 4, cell surface associated ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr11:68,008,245...68,053,242 JBrowse link
G Mug2 murinoglobulin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:155,164,061...155,236,894
Ensembl chr 4:155,164,011...155,236,475
JBrowse link
G Mvk mevalonate kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr12:42,141,391...42,158,893
Ensembl chr12:42,141,384...42,158,882
JBrowse link
G Mybl2 MYB proto-oncogene like 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:151,705,254...151,733,714
Ensembl chr 3:151,705,288...151,733,708
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor treatment
severity
ISO
IDA
IEP
mRNA:increased expression:liver (rat)
mRNA:increased expression:liver (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:9029167 PMID:12029619 PMID:15565109 PMID:29698666 PMID:21644509 More... RGD:6903288, RGD:7240567, RGD:7240695, RGD:7241004 NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor exacerbates
ameliorates
treatment
ISO
IEP
mRNA:increased expression:liver (human)
protein, mRNA:decreased expression:liver (human)
human cell line in a mouse model
protein:increased expression:liver (human)
mouse cell line in a mouse model
human gene and cell in a mouse model
RGD PMID:29022910 PMID:28370778 PMID:17615358 PMID:33575076 PMID:32144747 More... RGD:150520022, RGD:150520169, RGD:150521532, RGD:150521534, RGD:150524327, RGD:150524329, RGD:150524330, RGD:150524334, RGD:150530285 NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
JBrowse link
G Mzt2b mitotic spindle organizing protein 2B ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr11:85,024,120...85,031,960
Ensembl chr11:85,024,315...85,031,167
JBrowse link
G Nat2 N-acetyltransferase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
JBrowse link
G Nbn nibrin ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:9590180 PMID:9590181 PMID:9620777 PMID:10398434 PMID:10799436 More... NCBI chr 5:29,459,574...29,494,152
Ensembl chr 5:29,459,457...29,494,150
JBrowse link
G Ncapg non-SMC condensin I complex, subunit G ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr14:65,403,930...65,432,902
Ensembl chr14:65,404,163...65,432,902
JBrowse link
G Ncaph non-SMC condensin I complex, subunit H ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:114,371,937...114,399,178
Ensembl chr 3:114,371,941...114,399,180
JBrowse link
G Ncoa2 nuclear receptor coactivator 2 exacerbates ISO RGD PMID:28273073 PMID:22556267 RGD:153002573, RGD:153002576 NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
JBrowse link
G Ndc80 NDC80 kinetochore complex component ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:111,407,191...111,440,921
Ensembl chr 9:111,407,191...111,440,924
JBrowse link
G Neil3 nei-like DNA glycosylase 3 disease_progression ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver (human)
CTD
RGD
PMID:28284560 PMID:35693827 RGD:153344586 NCBI chr16:38,359,305...38,418,528
Ensembl chr16:38,359,371...38,418,527
JBrowse link
G Nek2 NIMA-related kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:103,405,818...103,419,063
Ensembl chr13:103,405,819...103,419,051
JBrowse link
G Nf2 NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor disease_progression ISO DNA, protein:SNP, increased expression:intron, liver
protein:decreased expression:liver
RGD PMID:29130106 PMID:27289045 PMID:26443326 RGD:150530489, RGD:150530504, RGD:11076529 NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
JBrowse link
G Nfe2l1 NFE2 like bZIP transcription factor 1 ISS OMIM:114550 MouseDO NCBI chr10:81,796,055...81,812,926
Ensembl chr10:81,800,366...81,832,318
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 ISO CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD
ClinVar
RGD
PMID:22561517 PMID:26619011 PMID:29018201 PMID:31546024 RGD:21201310 NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 disease_progression
treatment
ISO
IEP
associated with Chronic Hepatitis B;DNA:insertion/deletion:3'utr: -94ins/delATTG (rs28720239) (human) RGD PMID:19797428 PMID:25999787 RGD:40400751, RGD:152177911 NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
JBrowse link
G Nfkbia NFKB inhibitor alpha disease_progression
susceptibility
ISO CTD Direct Evidence: therapeutic
associated with Chronic Hepatitis B;DNA:SNPs,haplotype:3'utr,promoter: 826C>T,881A>G (rs2233406,rs3138053) (human)
associated with hepatitis B;DNA:SNP:promoter:-826C>T (rs2233406) (human)
CTD
RGD
PMID:22022477 PMID:19797428 PMID:25223483 RGD:40400751, RGD:40902986 NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
JBrowse link
G Nkx3-1 NK3 homeobox 1 treatment ISO mRNA:decreased expression:liver
human gene in a mouse model
RGD PMID:28972178 PMID:28972178 RGD:14401599, RGD:14401599 NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
JBrowse link
G Nlrc3 NLR family, CARD domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30081150 NCBI chr10:11,551,378...11,585,027
Ensembl chr10:11,551,356...11,584,398
JBrowse link
G Nlrc5 NLR family, CARD domain containing 5 ISO protein:increased expression:liver RGD PMID:27338800 RGD:15003194 NCBI chr19:10,477,638...10,581,023
Ensembl chr19:10,477,628...10,562,121
JBrowse link
G Nme1 NME/NM23 nucleoside diphosphate kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr10:78,907,036...78,929,659
Ensembl chr10:78,906,083...78,916,408
JBrowse link
G Nnmt nicotinamide N-methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:48,928,663...48,947,734
Ensembl chr 8:48,933,598...48,946,655
JBrowse link
G Nos2 nitric oxide synthase 2 treatment IEP RGD PMID:25999787 RGD:152177911 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
JBrowse link
G Notch3 notch receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23811326 NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
JBrowse link
G Nr1h2 nuclear receptor subfamily 1, group H, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr 1:95,041,967...95,047,358
Ensembl chr 1:95,041,967...95,047,377
JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 ISO
ISS
CTD Direct Evidence: marker/mechanism
mRNA:splice variant(s):liver (human)
intestinally expressed human gene in mouse model
OMIM:114550
CTD
MouseDO
RGD
PMID:23811326 PMID:25496033 PMID:23811326 PMID:23213087 PMID:24954587 RGD:14696796, RGD:14928330, RGD:14928334 NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
JBrowse link
G Nras NRAS proto-oncogene, GTPase disease_progression
severity
ISO